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Resumo 
 
 
O medronheiro (Arbutus unedo L.) é um arbusto endémico que cresce em toda 
a região Mediterrânica. Em Portugal, pode ser encontrado em todo o território 
continental, principalmente na zona sul do país. O fruto é utilizado na produção 
de compotas, marmeladas e aguardente, pelo que a composição química 
deste é relativamente bem conhecido quando comparado com as folhas. 
Actualmente, existem poucos estudos sobre a composição química das folhas, 
sendo que a maioria visa apenas o seu conteúdo em compostos fenólicos. 
Esta planta tem sido utilizada na medicina popular para tratar diversas 
doenças tais como distúrbios gastrointestinais, gastrite, problemas 
dermatológico, urológicos, renais e cardiovasculares. No entanto, até ao 
momento existem poucos estudos in vivo que atestem estas propriedades 
medicinais, o que justifica a realização deste tipo de ensaios. No caso da 
diabetes, que afecta milhões de pessoas em todo o mundo, existem apenas 
dois estudos sobre as propriedades antidiabéticas do extrato aquoso das 
raízes de A. unedo.  
O presente trabalho de mestrado avaliou o potencial antidiabético dos 
extractos aquosos das folhas e frutos do medronheiro. O estudo foi efectuado 
em ratos diabéticos (diabetes induzida por Estreptozotocina - STZ) 
alimentados com uma ração rica em gordura. Primeiramente foram 
optimizados os parâmetros de extracção para a obtenção do extrato aquosos 
do fruto. De seguida os extratos aquosos de folhas e frutos foram 
caracterizados em termos de teor em fenóis totais. O extrato aquoso das 
folhas apresentou uma maior concentração de fenóis totais do que o extrato 
aquoso do fruto. 
Ratos Wistar do sexo masculino foram injectados com STZ após serem 
alimentados durante 2 semanas com uma dieta rica em gordura. Desta forma 
induziu-se diabetes tipo 2, não dependente de insulina. Após a confirmação da 
condição diabética dos ratos, a dieta rica em gordura continuou a ser 
administrada aos animais. No entanto, as dietas foram suplementadas com 
extrato aquoso ou do fruto ou das folhas de Arbutus unedo L., num tratamento 
com a duração de 4 semanas. Os extratos foram administrados nas seguintes 
doses: 1.25g /kg peso corporal/dia no caso do extrato da folhas 0.5g /kg peso 
corporal/dia no caso do extrato do fruto. Efectuaram-se análises a parâmetros 
do sangue, hematológicos, à homeostasia mineral dos tecidos e à expressão 
de determinados genes após os animais serem sacrificados. 
O extrato do fruto apresentou uma tendência a regular os níveis de glucose no 
sangue. Outros efeitos benéficos foram atribuídos a este extrato, 
nomeadamente ao nível da regulação da expressão do gene de TNF-α a nível 
muscular. Este extrato também apresentou alguns efeitos ao nível da 
regulação da homeostase renal de zinco, embora não muito significativos. O 
extrato da folha provou ser mais eficiente a regular os níveis de insulina, a 
melhorar a resistência à insulina (HOMA-IR). Também apresentou uma 
tendência a regular os níveis de glucose no sangue. Ambos os extratos 
aumentaram de forma eficiente a sensibilidade à insulina (embora o extrato da 
folha o tenha feito de forma mais pronunciada). Obtiveram-se ainda bons 
resultados preliminares, uma vez que estes extratos demostraram que ocorreu 
uma tendência em termos de diminuição da concentração de creatinina e/ou 
fosfatase, de aumento do valor do parâmetro de Amplitude de Distribuição dos 
Eritrócitos medido como Desvio Padrão (RDW-SD), de aumento da 
concentração de linfócitos e diminuíram. Para ambos os extratos foram 
detectados efeitos antidiabéticos e anti-inflamatórios. 
Os resultados obtidos confirmam que A. unedo apresenta alguns efeitos 
terapêuticos, embora ligeiros. Os extratos desta planta melhoraram 
significativamente a sensibilidade à insulina mas não conseguiram regular 
significativamente o metabolismo da glucose. 
Este estudo foi o primeiro, num modelo animal de diabetes tipo 2 que avaliou o 
potencial antidiabético dos extratos aquosos dos frutos e folhas de Arbutus 
unedo L. 
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Abstract 
 
The strawberry tree (Arbutus unedo L.) is an endemic shrub, which grows in 
the Mediterranean region. In Portugal, it can be found through all the country 
but mostly in the south. The fruit is used to produce hams and jellies and 
firewater, reason why the fruit’s chemical composition is relatively well 
known, when compared to the leaves. Until now, there are only a few studies 
concerning the leaves’ chemical composition and the existing mainly focus 
on their phenolic content. 
This plant has long been used in folk medicine to treat a vast amount of 
illnesses like gastrointestinal disorders, gastritis, dermatologic and urological 
problems, kidney problems and cardiovascular diseases. However, very few 
studies in vivo have been performed about these medicinal properties until 
now. Diabetes is a pandemic disease that affects millions of people. There 
are only two studies about A. unedo root’s aqueous extract antidiabetic 
properties. 
This study evaluated the anti-diabetic effect of strawberry tree (Arbutus 
unedo L.) fruit and leaf aqueous extracts in streptozotocin (STZ) induced 
diabetic rats fed with a high-fat diet. Firstly the optimal parameters to obtain 
the fruit aqueous extract were established. After that, the leaves and fruits 
aqueous extracts were characterized in terms of total phenolic content 
(TPC). Leaf aqueous extracts presented a higher TPC concentration than the 
fruit aqueous extract. 
Male Wistar rats were injected with STZ, after a 2 week feeding with high-fat 
diet in order to induce non-insulin dependent type 2 diabetes. After 
confirmation of the rats’ diabetic state, the animals were fed with Arbutus 
unedo L. fruit aqueous extract or leaf aqueous extract added to the high-fat 
diet for 4 weeks. The extracts were given in the following doses: 1.25g /kg 
b.w./day for leaf extract and 0.5g /kg b.w./day for fruit extract. After the 
animals were sacrificed analyses were perform for blood indices, 
haematological indices, mineral tissular status and gene expression. 
Arbutus unedo L. fruit extract presented a tendency to lower blood glucose 
levels. More beneficial effects were seen for this extract in terms of 
regulating TNF-α gene expression in muscular tissue. Some effects in zinc 
renal homeostasis were also shown, although they were not very significant. 
The leaf extract, appeared to be more efficient in regulating insulin levels and 
improving HOMA-IR index. It also presented a tendency towards lowering 
blood glucose levels. Both extracts proved to efficiently improve insulin 
sensitivity (leaf extract in a larger extent). In this study, there were also some 
good preliminary results, as the groups supplemented with this extracts 
showed a tendency in decreasing serum creatinine and/or phosphatase 
concentration, improving the Red Cell Distribution Width measured with 
standard deviation (RDW-SD) and lymphocytes concentration. Positive anti-
diabetic and anti-inflammatory aspects were found for both aqueous extracts. 
The results obtained confirm the mid-therapeutically effects of A. unedo as 
the plant’s material effectively improved insulin sensitivity (HOMA-IR index) 
although failed to significantly modulate glucose metabolism. 
This study was the first in vivo trial on a type 2 diabetes animal model that 
evaluated the antidiabetic potential of Arbutus unedo L. fruits and leaves 
aqueous extracts. 
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1. Strawberry tree - Arbutus unedo L. 
1.1. Origin, characteristics, and botany 
Arbutus unedo L., commonly known as the strawberry tree, is a genus that 
belongs to the Vaccionioideae subfamily and a member of the Ericaceae family [1, 2]. It is 
an evergreen shrub, native of the Mediterranean region, being found in western, central and 
southern Europe, north-eastern Africa, Canary Islands and Palestine [3, 4]. In the 
Mediterranean region there are only 4 species and 2 hybrids [3]. This tree can live up to 
200 years [4]. 
The strawberry tree is characterized by being a busy shrub of 1.5m to 3m tall, so it 
is sometimes used as an ornamental plant [4, 5]. However, it can sometimes reach 9-12m 
in height as it has a spreading habit, but often this tree is much shorter, for example in the 
USA, it rarely exceeds 2.5-3.7m [2, 4, 5]. The plant is evergreen and broadleaved [2] and 
its geographical distribution can range from an altitude of 700-1000m above the sea [4, 5]. 
In northern Portugal, it usually ascends to 1200m above sea level [4, 6]. 
Strawberry tree prefers mild climates, where snow or hails do not occur very 
often, but it also needs a climate where the summer temperature and dryness is not very 
intense. Because of this, it is found mainly in coast and land areas where the climate is sub 
humid. Regarding the soil where it usually grows, this plant prefers siliceous or carbonated 
substrates [3]. Being considered the temperate area of Europe, the Mediterranean basin is 
the place that has all these characteristics and where this shrub better adapts. The 
Strawberry tree is thereby found in Portugal, Spain, France, Italy, Albania, Greece, 
Croatia, Bosnia, Serbia including the islands Balearic, Corsica, Sardinia, Sicily and Crete, 
spreading from the north of the Iberian Peninsula, going along the west coast of France 
until it reaches Ireland [3]. 
In terms of natural habitat, the tree prefers holm, cork and mixed forests, cliffs 
and canyons near rivers. It is also found in rocky soils although the shrub likes them fresh, 
deep and loose. It also tolerates industrial pollution and can prosper even if it is growing 
near the sea. The pH of the soil does not affect its growing but Arbutus unedo L.  likes to 
be full exposed to light, needs some humidity and resists low temperatures (-15ºC) and hail 
[4].   
This evergreen shrub has a short trunk with dense foliage. The bark is fissured 
(that reveals a red coloured young bark beneath) and usually peels off in small flakes, 
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which are mostly dull brown [4, 7]. The leaves (Figure 1a) which grow from the tree´s 
5mm long hairy pinkish stalks are alternate and simple, usually 5 to 10cm long with a 
glossy and brilliant green colour (can sometimes be dark green) [2, 7, 8]. They can also 
have a margin that is more or less serrated, usually 2–3 times as long as wide, glabrous 
with a petiole of 10 mm or less [7]. 
Arbutus unedo L. usually starts flowering in Autumn (September-October) and 
continues until the end of the winter, normally in February [2, 4]. The flowers from this 
plant are small, not having more than 5cm long and 8mm in diameter; bell-shaped and 
hermaphrodite (Figure 1 b). They are a bit like the blueberry flowers, having a white, 
pinkish or greenish colour. They assemble drooping panicles and have a soft honey scent 
[2, 8]. 
s b)  c)  d) 
Figure 1: Arbutus unedo L. a) leaves b) flowers with pink or white color c) fruit 
(mature) d) fruit and flower exist at the same time [2]. 
Strawberry tree mature fruits and flowers are existent at the same time, as the fruit 
takes 9-12 months to ripen. The coexistence of fruits and flowers gives the plant an 
immense beauty (Figure 1 d) [2, 4], reason why the strawberry tree can be used as an 
ornamental plant. The fruits look somewhat like strawberries as their colour ranges from 
yellow to scarlet and dark red. Their berries are spherical with about 2cm in diameter, 
covered in conical swellings (Figure 1 c). The fruit´s pulp is edible (although the taste is 
somewhat astringent) , soft and yellow and has seeds inside [4]. The resemblance between 
strawberries and this fruit only applies to looks, as the taste is very different [2, 9]. Even 
though these fruits are edible, their taste is not  very appreciated by the consumer, so they 
are rarely eaten as fresh fruits [2]. The fruit´s own name may suggest that, because the 
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Latin word “unedo” means “I eat one (only)”. So this can mean that the fruit is not very 
tasty or that  it so delicious that each person only needs to eat one [2]. 
                
1.2. Production in Portugal 
The shrub is implanted all over the Portuguese territory (Figure 2), with exception 
of the northern regions which are colder. It exists mainly in the south area of the country, 
but it does not grow in very dry areas of that region [4]. 
 
Figure 2: Arbutus unedo L. distribution in the Portuguese territory recorded until 
30/08/2011 (adapted from [10]). Areas in green represent the areas where the species was 
observed in its natural state. Yellowish green – que findings were validated internally by a 
collaborator of the database by photography or non-specialized publication. Green- the 
findings were validated by an expert. Dark green – the findings were validated by scientific 
work(s). 
Its presence is more relevant in some regions like the south of Rio Tejo namely in 
the region of Serra do Caldeirão and Serra de Monchique and the Algarve region [1, 9, 
10]. However, since this is an endemic plant and it is spread all over the country, it can 
also be found in the North-eastern part of Portugal, namely Trás-os-Montes [1, 11]. There 
are also large plantations of the strawberry tree in Perocabeço, Oleiros and Pampilhosa da 
Serra, with an extension of 15 and 36 hectares respectively  [1, 12]. In recent years, the 
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region of Rio de Alva in Penacova has also been known by its vast Strawberry tree 
plantation. This tree exists wildly across this region in woodlands near Rio Alva  [13]. 
 
1.3. Strawberry tree related products 
Even though the fruits are edible, they are not usually consumed or appreciated by 
people. The fruits are usually consumed as jams, marmalades, honey or distilled liquors. In 
rural areas, the fruit-based products are a source of complementary income. They are very 
popular and can be found in agriculture fairs proving the economic implication of this plant 
in the population’s income [14].  
Strawberry tree honey is another not so popular product, characterized by its 
strong and bitter taste which is very different from the taste people normally relate with 
honey. Strawberry tree honey is a known product of Mediterranean regions, such as Spain 
and Portugal [15]. 
Since ancient years, there are records of the use of several parts of this plant 
(roots, leaves, fruit and flowers) in folk medicine and phytotherapy to treat cardiovascular, 
dermatological, gastrointestinal, and urological disorders as well as diabetic and 
inflammatory ailments [16]. 
The fruit itself has already some alcoholic content, so its fermentation and 
subsequent distillation results in products such as firewater and spirit beverages. In 
Portugal, the fruits plantation is majorly aimed at the production of firewater, namely 
Aguardente de Medronho [4, 10, 12]. In other countries, like Italy and Greece, the fruit is 
also distilled which results in the beverages Corbezzolo and Koumaro [17]. 
Strawberry tree fruit aqueous extracts have recently been applied to yogurts, 
burgers and Frankfurters (German sausages) [18-21]. This extracts improved the product’s 
antioxidant activity, therefore increasing their stability [19]. The studies suggest that the 
fruit can be a good alternative to chemical food additives [18, 19]. 
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2. Arbutus unedo L. Chemical Composition 
2.1. Arbutus unedo L. Fruit’s Chemical Composition 
Strawberry tree fruits have been subjected to a vast amount of studies regarding 
their physic-chemical properties. One should notice that the fruit’s chemical composition 
can vary according to the region where it was planted, the year, its genetic characteristics 
as well as the exposition to sunlight, wind and the amount of water available to the fruit 
during its ripening [22-24].  
The general chemical composition of strawberry tree fruit available in literature is 
given in Table 1. This fruit has a moisture content that ranges between 46.82-71.89 g/100g 
of fresh weight, although this can vary according to light exposure, water content of the 
soil [22, 23, 25]. So, the dry matter of this fruit will be around 28.11-53.18%, this is 
considered high for a berry fruit, for example, strawberries and raspberries have a dry 
matter of only 10.2% and 15.5% respectively (% of edible portion) [26]. So we can 
consider the A. unedo fruit as a fruit with a low water content (which can be related with its 
high fiber content). 
The energetic value presented by these fruits ranges between 61.48 and 135.93 
kcal per 100 g of fresh fruit [23]. This fruit is considered to be acidic, as its pH is about 4.6 
[27], however  this value is high for a berry fruit, as berry fruits usually have a pH around 
3 and A. unedo fruit has a pH near the one of bananas (4.7) [26].  
Besides moisture, sugars are the main component of Arbutus fruit, representing 
from 14 to 32% of the fruits fresh weight, a value thought to be high for a fruit. All other 
berry fruits have lower sugar content; this fruit’s sugar concentration is very near the one 
of bananas, a fruit known for having an high sugar content [26]. From the total sugars, 
Ruiz-Rodrígues et aL. claim that fructose is the main sugar present in this fruit (15% of 
fresh weight), followed by glucose (7% of fresh weight) and sucrose (only 0.4%) [23], 
maltose is also present on small amounts (1.1% of the fruit’s dry weight) [28]. Comparing 
strawberry tree fruit to strawberries, black currant, red currant, raspberries and grapes, this 
fruit has a very high content of fructose (these berries have about 2-7% fructose) [26]. This 
fact can also explain why these berries have such a sweet taste since fructose is the 
sweetest of all non-synthetic carbohydrates [26]. Even the glucose content (can reach up to 
6.49 g/100g f.w) is considered high when compared to other fruits; for example grapes, a 
very sweet fruit, have a glucose content of 7.2g/100g of edible portion [26]. According to 
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Alarcão-e-Silva et al., carbohydrates can reach up to 50% of the total weight of dry fruits 
when the fruit is ripe [22]. In this study, the authors concluded that the sugar content of the 
berries increases with the maturation state, a factor that explains how mature state can 
affect the fruit’s chemical composition.  When the fruit is unripe, saccharose is the major 
sugar (87.7 ± 0.6 grams  per kg of dry fruit) available in the Arbutus fruit [22]. This can 
possibly be explained because of the enzymatic hydrolysis that occurs in the fruit’s 
carbohydrates and pigments during ripening [26]. 
Protein is also present in a considerable amount in strawberry tree fruit, ranging 
between 0.581–1.187 g per 100 g of fresh fruit, followed by ashes (0.685-1.058 g per 100 g 
of fresh fruit)  and fat (up to 0.779 g per 100 g of fresh fruit) [23]. The ash content is very 
similar to all other fruits according to literature [26]. Having about 0.8% fat, this fruit has a 
lipid content a bit higher than the values normally reported for fruits (0.1-0.5 % f.w.) [26]. 
The Arbutus fruit is a very good source of minerals, as its mineral content can 
reach up to 2.82 % (w/w) of the fruit’s fresh weight [27]. The study performed by Ruiz-
Rodríguez et al., showed that these fruits are especially rich in potassium (K), calcium 
(Ca), magnesium (Mg) and sodium (Na) [23]. The first one is present in high amounts, 
79.72 –323.14 mg/100 g of fresh weight, especially if we consider that minimum daily 
requirement for this mineral is estimated to be 782 mg [26]. Calcium content ranges 
between are 40.54–104.12 mg/100g f.w. and magnesium and sodium are present in 9.56–
45.85 and 4.33–9.94 mg/100g f.w. respectably. As we can see in Table 1, there are other 
minerals but in much smaller amounts. 
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Table 1: General physic-chemical characteristics of Arbutus unedo L. fresh ripped fruits. 
Properties  Values Reference(s) 
Moisture (g/100g)  46.82-71.89  [23, 25] 
Ash (g/100g)  0.685-1.058  [23] 
pH  4.6±0.10  [27] 
Energy (kcal/100 g )  61.48–135.93  [23] 
 Lipids (g/100) 0.299–0.779  [23] 
Macronutrients Proteins(g/100g) 0.581–1.187 [23] 
Carbohydrates (g/100g) 14.11-31.55 [23] 
 - Glucose  2.34–6.49 [23] 
 - Fructose  3.64–14.54 [23] 
 - Sucrose  Traces–0.483 [23] 
 - Maltose (% dry weight) 1.11±0.06  [28] 
Micronutrients Minerals (%(w/w)) 0.7-2.82 [23, 27] 
Na (mg/100g) 4.33–9.94 [23] 
K (mg/100g) 79.72–323.14 [23] 
Mg (mg/100g) 9.56–45.85 [23] 
Ca (mg/100g) 40.54–104.12 [23] 
Fe (mg/100g) 0.354–1.856 [23] 
Cu (mg/100g) 0.073–0.208 [23] 
Mn (mg/100g) 0.038–0.178 [23] 
Zn (mg/100g) 0.188–0.762 [23] 
Vitamins(mg/100g):   
 - Vitamins C 
( total)  
122.0–262.7  [23] 
 - Carotenoids (total) 0.064±0.014  [29] 
 - β-Carotene 0.219-0.890  [23] 
 - Lycopene  0-0.262  [23] 
 - Total Tocopherols 
(mg/100 g dry weight) 
23.46 ± 0.26  [25] 
Soluble solids (% Brix)  21.05 ± 0.07  [24] 
Total phenols  
mg GAE/100g 
 590-1973.6  
 
[23, 24] 
Total dietary fibres (g/100 
g) 
Total: 10.04–22.27 [23] 
Soluble dietary fibres 2.17–4.19  
  
[23, 24] 
 Insoluble dietary fibres 7.86–18.55 [23] 
Organic acids (mg/100g) Oxalic acid 48.44–146.75  [23] 
Malic acid 203.3–299.6 [23] 
Fumaric acid 0.489–1.114 [23] 
Sterols (mg/100g) Total: 6–30 [30] 
 - β-sitosterol 
- Campesterol 
- Stigmasterol 
- Cholestan-3-one 
6–30 
1 
Traces 
Traces 
 
 
The amount of vitamins and carotenoids in Arbutus fruit are higher than the 
amounts present in other fruits. Strawberries for example have a vitamin C content of 64 
mg/100g f.w. and orange, known in fold medicine for having a high vitamin C content only 
presents a concentration of this vitamin of about 50 mg/100g f.w. [26]. Once again this 
parameter can vary according to the fruit’s ripening stage [22]. The total vitamin C content 
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was determined by Ruiz-Rodríguez et al., who concluded that the composition of this fruit 
contains up to 262.7 mg/100g of f.w. of total vitamin C [23], while a higher amount was 
found by Alarcão-e-Silva et al., whose samples contained 542 ± 11 mg of ascorbic acid per 
100 g of dry matter of the fruit (when it is ripe) [22]. When compared to the quantity 
present in other fruits, like peaches, apples and cherries [26, 29] the amount of vitamin C is 
considered low. Strawberries, for example, have an ascorbic acid content of about 60 mg 
per 100 g of edible portion, a much higher value; on the other hand, pears only have about 
1-4% [26]. The total vitamin E present in  strawberry tree fruit  is about 23.46 ± 0.26 
mg/100 g dry weight of total tocopherols, being α-tocopherol the most important form of 
vitamin E present, with 21.98 ± 0.18 mg/100 g dry weight [25]. Carotenoids are present in 
the fruit too, especially β–carotene, which is present in the amount of 0.219-0.890 mg per 
100g of Arbutus fruit fresh weight [23]. Total carotenoids were quantified by Pallauf et al., 
stating that the fruit has an amount of 0.0647±0.014 mg per 100 g edible portion [29]. 
Alarcão-e-Silva et al. refer the changes in the amount of β-carotene with fruit ripening, 
ranging between 38.1 ± 3.7 mg/100 g of dry matter (unripe) and 70.9±5.2 mg/100 g of dry 
matter (mature) [22]. Lycopene is also present, but in very small amounts, 0-0.262 
mg/100g f.w. [23]; it can be responsible for the fruit’s bright red colour. 
Regarding dietary fibre content, Arbutus unedo L. fruits can have a total amount 
of fiber content that varies between 10.04–22.27 grams per 100g of fresh fruit  [23]. This 
value is higher than the one of shell-nut fruits (which ranges between 2-13.5% of fresh 
edible portion) and it is considered very high for a fruit [26]. The dietary fibre of the fruit 
can be divided into soluble and insoluble fibre. Soluble fibre is present in lower amounts 
(2.17–4.19 g/100g f.w. [23, 24]) than insoluble fibre (7.86–18.55 g/100g f.w. [23]). ºBrix 
of A. unedo fruits is 21.05 % [24]. ( °Brix is a measure of the soluble solids in solution and 
it can be used as an indicator of sugar concentration and maturity [26, 31].) 
 The organic acids identified in the study of Ruiz-Rodríguez et al. were oxalic 
acid (48.44–146.75 mg/100g f.w.), malic acid (203.3–299.6 mg/100g f.w.) and fumaric 
acid (0.489–1.114 mg/100g f.w.) [23]. Alarcão-e-Silva et al. reported that, again, these 
values depend on ripening state, and claimed that quinic acid is the major organic acid 
present in the fruit (about 7.35g/100g of dry weight when the fruit is unripe and 5.99g 
when the fruit is ripe) [22]. L-Malic and citric acids are considered the major organic acids 
of fruits, whereas Malic acid is predominant in pomme and stone fruits, while citric acid is 
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most abundant in berries. So A. unedo fruit has an organic acid profile similar to the one of 
pomme fruits [26, 31]. 
Sterols were also present in strawberry tree fruits collected from Penacova in 
central Portugal. Several have been found, namely  β-sitosterol, campesterol, stigmasterol 
and cholestan-3-one [30]. The sterol found in higher amount was sitosterol, which 
represented alone almost all of the sterol content of the fruit. As the normal dietary intake 
of phytosterols ranges from 200–400 mg/day, one can say that Arbutus unedo L. fruits are 
not particularly rich in this components [26]. 
The phenolic fraction of strawberry tree fruit is of great interest, mainly because 
of the health promoting effects attributed to these compounds. The total phenolic content 
(TPC) of the fruit can vary between 590-1973 mg of Galic Acid Equivalents (GAE) per 
100g of fresh fruit [22, 23]. However, these values can vary according to ripening stage, 
area, study and method of analyses used reason why the TPC can vary so much. The 
highest reported TPC was the one reported by Ruíz-Rodríguez et al. of 1973.6 mg 
GAE/100g [23]. In the Arbutus unedo L. berries, various classes of phenolic compounds 
have been identified, mainly in the flavonoid class. The phenolic fraction contained in the 
fruits of Arbutus unedo L.  is very diverse and can include several chemical classes, such 
as tannins, flavonoids, anthocyanins, ellagic acid derivatives and gallic acid derivatives 
[28, 29, 32, 33]. The determination of total concentration of anthocyanins was also 
performed by Pallauf et al. reaching a value of 3.77 mg per 100 g of fresh fruit [29]. 
Proanthocyanidins are another chemical group within the flavonoids present in the berries, 
being present in 27.46 mg per 100 g of edible fruit [29]. Another class of phenolic 
compounds present in A. unedo fruits are the ellagic acid derivatives, existing in the 
concentration of 1.54 mg per 100 g of fresh fruit [29]. Flavonols are also present in the 
fruits and were once more quantified by Pallauf et al. The total amount of flavonols is 1.14 
mg per 100 g of edible fruit [29]. According to Pallauf et al., the main Flavan-3-ol present 
in Arbutus unedo L. fruits is catechin followed by gallocatechin (3.64 and 4.16 mg per 100 
g of fresh weigh respectably) [29]. The phenolic acids available in the Arbutus unedo fruits 
were studied in the reports of Ayaz et al., and Guimarães et al. [28, 33]. Gallic acid is the 
main phenolic acid present in the fruits (10.7 mg per 100 g of dry fruit) [28]. Some tannins 
were also identified in Arbutus unedo fruits, the tannin found in the highest concentration 
was galloylquinic acid (8.65 mg per 100 g of dry weight) [33]. 
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2.2. Arbutus unedo L. Leaves Chemical Composition 
Studies about the leaves’ chemical composition regarding other chemical families 
rather than polyphenols are still missing. Many of these studies are more focused on 
antioxidants than on other families of compounds. The composition of the fruits is 
relatively well-known when compared to leaves (Table 2).  
 
Table 2:  General chemical composition of Arbutus unedo L.  leaves. 
Compound(s)  Values Reference(s) 
Vitamins (% of dried 
weight) 
α-Tocopherol  0.0132 [34] 
Essential oil (% of 
essential oil) 
(E)-2-decenal 
α-Terpineol 
Hexadecanoic acid 
(E)-2-undecenal 
12.0 
8.8 
5.1 
4.8 
[35] 
Terpenoids α-Amyrin acetate 
Betulinic acid 
Lupeol 
Not quantified [36] 
Phenolic Compounds 
(mg /100 g f.w.) 
Total ( mg GAE/g d.w.) 
 
53.3–113.6  [8] 
 
Arbutin   
Ethyl gallate 
p-hydroxybenzoyl-arbutin 
Galloyl arbutin 
Catechin 
Gallocatechin  
62.7 
44.0 
2.5 
11.4 
54.6 
35.5 
[37] 
 
 
 
Quercitrin (mg/g of dry leaf) 
Isoquercitrin (mg/g of dry leaf) 
Hyperoside (mg/g of dry leaf) 
Rutin 
Chlorogenic acid (mg/g of dry 
leaf) 
1.21-2.20 
0.07-0.33 
0.11-0.35 
Traces 
0.61-1.46 
[38] 
 
In terms of Vitamins, only vitamin E was detected and studied in Arbutus unedo 
L. leaves.  Kivcak et al. studied Arbutus leaves in Turkey and identified the presence of  α-
Tocopherol in the leaves by TLC [34]. The authors also found out that this component can 
vary according to the time of the year. In March, the leaves have a higher amount of this 
molecule. Maximum content of tocopherol was determined by colorimetry as 0.01328% of 
dried weigh. The same authors also studied the leaves in terms of essential oil composition. 
Leaves collected in Izmir-Cicekliköy (Turkey) had in their composition (E)-2-decenal, α-
terpineol, hexadecanoic acid, and (E)-2-undecenal [35]. Finally, Gaspar et al. have studied 
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the Arbutus unedo leaves in terms of terpenoids. The terpenoids identified were  α-amyrin 
acetate, betulinic acid and lupeol [36].  
Perhaps the best studied family of compounds in the A. unedo leaves are the 
phenolic compounds. The TPC of A. unedo leaves can vary between 53.3 and 116.3 mg 
GAE/g of dried leaves according to Malheiro et al. [8]. 
There is a large variety of phenolic compounds that have been identified in the 
leaves of Arbutus unedo L. in different studies. These include compounds such as tannins, 
flavonoids, phenolic glycosides and hydroquinones [7, 8, 37, 38]. Identification and 
quantification of these polyphenols has been done in the works of Fiorentino et al. and 
Maleš et al. [7, 37, 38]. Fiorentino et al. identified twelve compounds, and according to 
this work, the polyphenols present in higher concentration were arbutin (62.7 mg per 100g 
of fresh leaves), catechin (54.6 mg/100g fresh leaves) and ethyl gallate (44.0 mg/100g 
fresh leaves) [37]. In the two works of Maleš et al. [7, 38] polyphenols were identified by 
TLC and quantified, using leaves collected in different times of the year. In this work five 
compounds were identified and quantified, with their concentration varying according to 
the time of the year: quercitrin , isoquercitrin, hyperoside, rutin (traces that were not 
possible to quantify) and chlorogenic acid [38]. One of the main conclusions was that the 
concentration of phenols varies during the months. For example, leaves should be collected 
in January to obtain the highest concentrations of hyperoside and quercitrin, in June, July, 
and October for chlorogenic acid, and for the fraction of quercitrin and isoquercitrin in 
November. Hydroquinones were also identified in A. unedo leaves by Fiorentino et al. 
[37]. These hydroquinones belong to the arbutin class. p-Hydroxybenzoyl-arbutin and 
galloyl arbutin are available in the leaves of A. unedo in the concentrations of 2.5 and 11.4 
mg per 100 g of fresh leaves respectively [37]. In the same work, two flavan-3-ols were 
identified: catechin (54.6 mg/100g of fresh leaves) and gallocatechin (35.5 mg/100g of 
fresh leaves). 
 
3. Arbutus unedo L. aqueous extracts: properties and biological effects 
All throughout the Mediterranean and North African countries, Arbutus unedo L. 
has long been used in the region’s folk medicine. The entire plant is reported to have 
medical properties. Almost all parts of the plant are used in infusions, decoctions etc. The 
health promoting characteristics attributed to Arbutus unedo are related with the treatment 
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of gastrointestinal and urological problems, hypertension and cardiac diseases, diabetes 
and as anti-inflammatory and anti-microbiological effects.  
The leaves are widely used in traditional medicine and have a lot of health 
benefits. They are considered to be strong antioxidants, to have vasorelaxant effects, to 
have antimicrobial activity, to improve cardiovascular health, to help modulate 
inflammatory processes and to have some anti-tumour properties [16]. Some studies are 
now trying to relate these effects with its compounds (namely phenolic compounds present 
is the A. unedo leaves). However, once more, very few studies have been performed and/or 
have effectively proved these effects which have been reported by ancient medical 
practices. 
 
3.1. Chemical composition of aqueous extracts of fruits, leaves and roots  
In a study from 2011, Mendes et al. compared the antihemolytic and radical 
scavenging activities of strawberry tree leaf and fruit aqueous extracts [39]. The total 
phenolic content of leaf and fruit aqueous extracts was also measured. Leaf aqueous extract 
showed a higher phenolic content (170.3 mg GAE/g extract) than fruit aqueous extract 
(16.7 mg GAE/g extract). In this same study by Mendes et al., the authors compared the 
amount of phenolic compounds present in the Arbutus unedo L. fruit and leaf aqueous 
extract which were previously identified by LC–DAD/ESI-MS analysis. Table 3 lists the 
phenolic compounds identified in this study. It is possible to conclude that the leaves 
aqueous extract have a greater amount of compounds when compared to the fruits aqueous 
extract [39]. To note that this study only identified the compounds, not quantified them, so 
more assessments in this matter are needed. 
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Table 3: Comparing the phenolic compounds present in the Arbutus unedo L. fruit and leaf 
aqueous extract [39]. 
Compounds identified Fruit Leaf 
Gallic acid glucoside x x 
Gallocatechin dimer  x 
Galloylquinic acid x x 
Gallic acid x x 
Galloyl shikimic acid x x 
Prodelfinidin dimer  x 
Procyanidin dimer x x 
Catechin monomer x x 
Digalloylquinic acid x x 
Strictinin ellagitannin x x 
Galloyl derivative x x 
Procyanidin gallate  x 
Myricetin glucoside  x 
Quercetin hexose galloyl derivative  x 
Procyanidin gallate  x 
Myricetin glucoside  x 
Myricetin rhamoside x x 
Quercetin glucoside x x 
Quercetin derivative (arabinoside/xyloside)  x 
Kampherol galloylglucoside  x 
Ellagic acid arabinoside/xyloside  x 
Ellagic acid rhamnoside x x 
Ellagic acid x x 
Quercetin hexoside derivative  x 
Kampherol xyloside  x 
Kaempferol rhamnoside  x 
Kampherol galloylxyloside  x 
Kaempferol hexoside derivative  x 
Quercetin derivative (Rhamnoside/Hexoside)  x 
Kampherol derivative (Rhamnoside/Hexoside)  x 
Quinic acid derivative x  
Digalloyl shikimic acid x  
Ellagitannin derivative x  
Trigalloyl shikimic acid x  
Gallotannin x  
 
The Arbutus unedo L. roots’ composition has not been largely studied and little is 
still known. Dib et al. have done two studies about this matter from roots collected in the 
Terni forest (Tlemcen, Algeria) [40, 41]. On a first study, they have isolated several 
phenolic compounds such as (+)-catechin, (+)-catechin gallate from the roots of A. unedo, 
using a water/methanol/acetone mixture. In the same study, other compounds were  
identified by GC-MS: 4-hydroxy phenyl acetic acid; gallic acid; protocatechic acid; 
benzoic acid, 4-(acetyloxy)-3-methoxy-,methyl ester; gentisic acid; caffeic acid; catechin; 
phthalylglycine and bis(2-ethylhexyl) phthalate [40]. On the second study, they have made 
a phytochemical screening of the roots and quantitative analysis. In the water extract, they 
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have detected several types of compounds such as quinones, anthocyanins, anthraquinones, 
flavonoids and tannins [41]. After the quantitative analysis they determined that A. unedo 
roots had a anthocyanin content of 3.65 mg/g f.w., total flavonoid content of 0.56 mg/ g 
f.w. and a flavones and flavonols content of 0.17mg/g f.w. [41]. 
Once more these studies focus more on antioxidants than on other families of 
compounds. 
 
3.2.  Arbutus unedo L. aqueous extracts’ bioactive properties 
Testing the bioactivity of extracts in vivo after the laboratory chemical assays is 
very important for research. In the work of Fortalezas et al. the antioxidant properties of 
the strawberry tree fruit were assessed in vitro in a neurodegeneration cell model [42]. 
Although the hydroalcoolic extract revealed a high phenolic content in the in vitro test 
(16.46 mg GAE/ g of dry weight), the extract caused no effect on cells viability. So this 
study was a good example of the importance of the need to evaluate the biological function 
of phenolic compounds in vivo, or even in a cell model in order to validate their in vitro 
antioxidant activity. More in vivo studies of the extracts of Arbutus unedo L. are thereby 
needed, because sometimes the in vivo effects are a lot different than the ones that were 
expected. 
In another study from 2009, conducted by Andrade et al., Arbutus unedo L. 
ethanolic and acetone extracts showed to have an high content of phenolic compounds 
(254.50 and 328.58 mg GAE/g plant extract).  However,  A. unedo extracts caused  the 
decrease of cell viability (mainly because they were able to decrease mitochondrial 
dehydrogenases activity), regardless of the solvent used for the extraction [19]. This works 
suggests that there can be a relationship between cytotoxicity and polyphenolic fractions of 
vegetal extracts, because a high amount of phenols may be linked to a pro-oxidant effect.  
One of the main conclusions of Guimarães et al. was that  bioactivity of the 
strawberry tree fruits can be more related to the phenolic compounds present in each 
extract than to their concentration [11]. Two different enriched phenolic extracts were 
prepared in order to evaluate and compare their bioactivity: non-anthocyanin phenolic 
compounds enriched extract and anthocyanins enriched extract. Various fruit extracts were 
prepared. Their phenolic content was measured and the antitumor activity and 
hepatotoxicity were evaluated. A. unedo fruit extracts revealed to have a higher bioactivity 
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and the highest antioxidant activity in all the in vitro assays (which the authors relate to the 
presence of galloyl derivatives and to the presence of flavan-3-ols).  A. unedo also had the 
best antitumor inhibition effect. This way, this study related biological effects to different 
compounds. So phenolic extract, in case of Arbutus unedo L., was more bioactive that 
anthocyanin extract [11]. 
In the study by Dib et. al moderate antibacterial activity was reported for water 
extract and phenolic extract of A. unedo against E. coli and Staphylococcus aureus [41]. 
This activity was attributed to the phenolic compounds detected in both water and phenolic 
extracts such as quinones, anthraquinones, flavonoids, tannins and anthocyanins. 
Arbutus unedo L. antiaggregant effects in human platelets was also evaluated by 
El Haouari et al. [43]. Extracts from Arbutus unedo were obtained by extraction with 
water, diethyl ether and ethyl acetate. Platelets were treated with increasing concentrations 
of crude aqueous (0.015-1.5 mg/mL), ethyl acetate or diethyl ether extracts. All the 
extracts reduced platelet aggregation evoked by thrombin, had strong ROS scavenging 
activity, reduced store-operated Ca
2+
 entry induced by thrombin and also reduced basal and 
thrombin-stimulated tyrosine phosphorylation. All these parameters make Arbutus unedo 
L. extracts good antiaggregants which is likely to valorise A. unedo as a good treatment or 
prevention treatment to cardiovascular diseases. 
The aim of the study by Afkir et al. was to evaluate if the treatment with Arbutus 
unedo L. leaf and root aqueous extracts reduced hypertension, by inhibiting nitric oxide 
synthase [44]. This study used an in vivo approach as rats were treated with 250 mg per kg 
of each extract each day. The vascular reactivity of the rat’s aorta was measured ex vivo. In 
conclusion, the treatment of rats with A. unedo aqueous extract regressed hypertension 
development, prevented the myocardial hypertrophy; ameliorated vascular reactivity, and 
renal functional parameters. Authors relate these findings with the presence of polyphenols 
in the extracts that modulate the NOS activity. The authors also reported that the effect was 
greater and more efficient with root than leaf extract.  
As far as hypertension is concerned, this plant is used in traditional medicine 
against this disease. Typically, an infusion of roots or leaves can be made. Some more 
studies were done regarding the plant’s anti platelet aggregation activity. In various 
studies, the leaf and root aqueous extract showed: an inhibition of thrombin-induced 
platelet aggregation, which the authors related to the tannins present in the leaves [45];  
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provoked an in vitro inhibition of aggregation of rat platelets (effect that could be 
attributed to a number of phytochemicals present in the roots) [46]. This type of extract had 
also a vasorelaxant activity in rat isolated aorta (as the tannins and catechin gallate present 
in the leaf methanolic extract  showed a strong vasorelaxant activity) [47]. 
Regarding inflammation, Mariotto et al. performed a study using an animal model 
of acute inflammation and a cellular model using human alveolar epithelial cells and the 
human monocytic leukemia cells [48]. Rats were treated with carrageenan in order to 
induce lung inflammation. Rat cells and human alveolar epithelial cells were also 
cultivated.  Carrageenan has administrated to rats in order to induce lung inflammation. 
Arbutus unedo leaves aqueous extract were administered to both groups (in a dose 
correspondent to 20 mg GAE/kg). The aim of the study was to evaluate if the 
administration of this extract affected the following: STAT1/3 activation, TNF, IL-1 and 
IL-6 production in pleural exudate, lung iNOS, COX-2 and ICAM-1 expression, neutrophil 
infiltration, the nitration of cellular proteins by peroxynitrite, lipid peroxidation, 
prostaglandin E2 levels, nitrite/nitrate levels and the amount of lung injury. In summary, 
this report lead to the conclusion that Arbutus unedo L. aqueous extract reduced the 
production of IL-6 in the human cell lines which strongly inhibits the activation of STAT3. 
This way it prevented the formation of other pro-inflammatory cytokines such as TNF-α 
and IL-1. In the carrageenan-induced rats there was a decreased recruitment of neutrophils 
and a down regulation of the expression of iNOS and COX-2 which finally led to the 
decrease of inflammation and of tissue injury. The study concluded that inflammation was 
significantly attenuated by the treatment with A. unedo extract. Once again, authors relate 
this finding with flavonoids that are known to be present in this plant [48]. 
 
3.2.1. Studies on Antihyperglycaemic Activity 
Since the fruit and leaves can be easily found and consumed by the population [4, 
14], they can easily be combined in the treatment of type 2 Diabetes or/and can be used to 
reduce the risk of this disease. The roots of A. unedo are claimed to have antidiabetic 
effects [49, 50]. However, no antidiabetic studies have been done about the antidiabetic 
properties of fruits and leaves of Arbutus unedo until this date [16, 49].  
Regarding the antidiabetic effects of Arbutus unedo L., only two studies are 
known. Bnouham et al. have studied the hypoglycaemia effect of Arbutus unedo root 
19 
 
aqueous extracts in neonatal streptozotocin-induced diabetic rats under chronic treatment 
[49, 50].  These studies have been conducted in an animal model with STZ-diabetic rats. 
They showed that Arbutus unedo decreases blood glucose levels. According to Bnouham et 
al. the doses 400mg of root aqueous extract per litre and 500mg of root aqueous extract per 
kg of body weight exhibit plasma glucose lowering effect, in Wistar rats [49, 50].   The in 
vitro study of glucose utilization was also tested and the data suggest that the combination 
of insulin and extract (insulin at 2 UI/mL and aqueous extract of A. unedo at 1 mg/mL) 
potentiates its activity and enhances the utilization of glucose [49].  
Taking in consideration this two works by Bnouham et al., physiological 
characteristics of Wistar rats (body weight of about 300g and daily water intake of 20-50 
ml a day [51]), one can estimate that the doses given were 20mg of extract each day [49] 
and 150mg of extract each day [50].  
So, according to these works, a dose between 20 and 150mg of root aqueous 
extract will present and antidiabetic effect in rats. These doses can serve as reference for 
further works with other parts of the Arbutus plant. 
 
4. Diabetes Mellitus: some considerations and study model 
4.1. Pathology and biochemical changes 
Diabetes Mellitus is a disease caused by anomalies in glucose homeostasis and 
can be divided into two types: a non-insulin dependent (type 2) and another caused by 
deficient insulin production (type 1) [52]. Chronic hyperglycaemia is a characteristic of 
diabetes due to poor glucose regulation caused by decreased insulin secretion and/or by 
decreased insulin activity.  Insulin is a hormone produced by the pancreatic β-cells whose 
main function is to maintain blood glucose homeostasis by increasing glucose uptake by 
cells, increasing glycogen production and glycolysis and signalizing cells to increase 
protein and fatty acids synthesis [52]. This hormone can also act indirectly in fatty acids 
homeostasis as it increases fatty acids and triglyceride synthesis in liver and fat tissues and 
decreases lipolysis in adipocytes which is responsible for the body fat increased storage 
[52]. 
Diabetes type 2 is a very common health problem in developed countries, 
particularly in the USA and in Europe. The World Health Organization claims that 347 
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million people worldwide have diabetes and will be the 7th leading cause of death in 2030 
[53]. 
Type 2 diabetes mellitus is a chronic disease that is associated with obesity and 
excess of sugar and fat in the diet. In type 2 diabetes there is deficient production of insulin 
or a decrease uptake of glucose by the cells [52]. There is a progressive development of 
hyperglycaemia and the insulin resistance (mainly in muscle and liver tissues) due to 
increased body fat. This type of diabetes can remain “silent” during year as initially 
pancreas is able to produce more insulin in order to try to overcome the body’s insulin 
resistance. However, as this is the result of  a diet rich in sugar and poor glycaemic control, 
the pancreas starts to shut down since there is a progressive failure of the β-cell output, 
resulting first in glucose intolerance and then ultimately in type 2 diabetes. Glucose 
metabolic pathways and organ systems homeostasis are affected resulting in accelerated 
lipolysis, hyperglucagonemia and increased glucose reabsorption in kidneys. The increased 
gluconeogenesis results in both renal and hepatic glucose release. In type 2 diabetes 
patients there is an accumulation of glycogen in the kidney, which leads to the increased 
renal glucose release [52, 54]. Other effects of diabetes is a high percentage of glycated 
haemoglobin as a high concentration of glucose in the blood can lead to its non-enzymatic 
linkage to lysine residues of a variety of proteins, making this parameter a direct reflection 
of a mean blood glucose levels [52]. Protein glycosylation can also take place in cellular 
membrane proteins leading to disrupted cellular signalling  Microalbuminuria is a 
characteristic of diabetes and it is defined as the albumin expression rate being a signal of 
early renal damage [52]. 
Chronic hyperglycaemia caused by diabetes is associated with long term cellular 
damage and multiple organ failure which can lead to retinopathy, nephropathy, neuropathy 
heart disease and atherosclerosis [52]. 
 
4.2. Insulin Cascade 
A series of metabolic responses in cells are induced by insulin. The insulin 
pathway is illustrated in figure 3. Firstly, insulin binds to its receptor inducing the auto 
phosphorylation of a number of tyrosine residues. Another group of proteins, the insulin 
receptor substrates (IRS) have a phosphotyrosine-binding (PTB) domain which recognises 
the tyrosine residues and are recruited to the receptor at the cell membrane. The IRS 
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molecules are this way phosphorylated at their numerous tyrosine residues by the insulin 
receptor. Some of these phosphorylated residues are then recognised by the SH2 (Src 
homology 2) domain of the p85 regulatory subunit of PI 3-kinase. PI 3-kinase has itself a 
catalytic subunit, the p110, which phosphorylates another protein at the plasma membrane 
of the cell, the PtdIbs(4,5)P2 generating a second messenger, the PtdIns(3,4,5)P3. This, on 
the other hand, stimulates insulin-dependent processes. When insulin binds to its receptor 
another protein is also phosphorylated, the Cbl. The Cbl forms a complex with the adaptor 
protein CAP which is recruited to a region of the plasma membrane denominated RAFT. 
In the plasma membrane Clb also interacts with the adaptor protein Crk which is associated 
with factor C3G. Members of the GTP-binding protein family, TC10 are activated by C3G, 
throughout an unknown mechanism this GTP-binding proteins activate effector molecules 
to promote GLUT4 translocation [55-57]. 
 
 
Figure 3: The insulin pathway  [56]. 
Insulin receptor substrate family proteins (IRS) are a family of proteins that 
transmit signals from insulin to intracellular pathways. One of the pathways they mediate 
is the PI(3)K/Akt pathway. P110 is involved in the phosphorylation of the protein PI(3)K 
(phosphatidylinositol 3-kinase) which activates a serine-threonine kinase known as Akt or 
22 
 
protein kinase B (PK-B). Akt can be recruited to the cell membrane where is activated. 
After it can have multiple functions. It can phosphorylate multiple substrates who act on 
gluconeogenesis and glycogenolysis pathways, it can inhibit glycogen synthase kinase-3 
(GSK-3) inducing glycogen synthesis, it can induce protein synthesis, regulate cellular 
metabolism and gene expression. Akt is also known to play a role in GLUT4 translocation 
[55-57]. The different IRS proteins seem to serve different functions at the cellular level, 
probably having different distribution throughout the tissues. For example, studies showed 
that rats lacking IRS-2 gene have a diabetic phenotype [56]. 
 
4.3. Glucose Transporters 
GLUT are a class of genes that encode a family of plasma membrane proteins 
named Glucose Transporters (GLUTs) whose function is to mediate the transport of 
glucose over the cellular membrane. Various types of GLUTs exist, namely GLUT-2 and 
GLUT-4. GLUT-2 is expressed in liver cells and pancreatic β-cells as well as kidney 
tubular cells. On the other hand, GLUT-4 is mainly expressed in fat tissues although it can 
also be present in other types of striated muscular tissues. GLUT-2 isoform mediates the 
bidimensional transport of glucose in the hepatocyte and is thought to be involved in the 
glucose sensing mechanism of the pancreatic cells. The GLUT4 isoform changes in 
response to insulin and is responsible for most of the insulin-stimulated uptake of glucose 
[55]. 
 
4.4. Type 2 Diabetes effects on microelement homeostasis 
Several studies report that diabetes can disturb mineral homeostasis, namely 
copper, iron and zinc [58-67]. Zinc is a trace element required to multiple cell regulatory 
reactions and has a role in diabetes development and glucose metabolism. It plays a role in 
insulin production secretion and storage, as Zn transporter (ZnT8) regulates insulin 
secretion from the pancreatic β-cells. Besides, zinc deficiency may potentiate insulin 
resistance thereby affecting the glucose uptake [59, 64]. Zinc metabolism is disturbed by 
high glucose levels in diabetes mellitus. In diabetic patients there is also an  increased loss 
of zinc in urine due to polyuria [59]. Zinc tissular levels can be also affected as rats used as 
a model of type 2 diabetes presented lower zinc levels in kidneys, testis and fat, but higher 
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zinc levels in spleen, pancreas and prostate, which indicate a redistribution during the 
diabetic state [59].  
Copper is another trace mineral that also plays a role in various enzymes catalytic 
centres. It also protects the body against oxidative damage and has a direct influence in 
lipid metabolism. Disrupted tissular copper levels are thought to negatively affect some 
metabolic pathways related with diabetes [64]. Higher  serum concentration of Cu was 
found in type 2 diabetic patients and an association between these high values and diabetes 
complications was established [58]. There is also a relationship between an high-fat diet (in 
Zargar study, obese patients with diabetes), diabetes and a slight elevation of copper levels 
[68].  
Iron is another essential mineral that plays multiple functions in physiology, 
mostly associated with redox reactions and transporting oxygen by haemoglobin. Iron is 
stored in the form of ferritin wich is a biomarker of iron status. Recently it was found that 
serum ferritin levels are elevated in diabetic patients [64, 66]. Higher levels of ferritin 
indicate increased tissular iron deposition [66]. It is also known that diabetes can be a risk 
factor for hemochromatosis which elevates the serum iron levels. A recent study a 
demonstrated that administration of iron can induce diabetes in animals, establishing a 
positive association between elevated iron stores and type 2 diabetes [66]. Iron can also 
interfere with proper insulin metabolism in liver and pancreas as elevated iron levels may 
lead to its deposition in the pancreatic ß-cells. This results in impaired insulin secretion and 
high iron hepatic stores can cause insulin resistance by preventing insulin to bind with 
liver’s receptors [66]. 
 
4.5. Diabetes and inflammation 
Both type 1 and type 2 diabetes are associated with increased inflammation as this 
state is thought to mediate the development of insulin resistance and pancreatic β-cell 
dysfunction. Diabetes causing oxidative stress is related with nephropathy and retinopathy 
[69]. Numerous inflammatory response associated molecules are increased in diabetic 
patients. Diabetic patients were also found to have decreased immunity as the expression 
of molecules as IL-2R and CR3 appeared to be downregulated [70]. These molecules play 
a key role in inflammatory response as being responsible for lymphocyte and monocyte 
proliferation. High fat feeding or over nutrition can be directly involved in an increased 
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inflammatory state. High fat diets can lead to increased body fat and adipose tissue that 
secrets adipokines such as TNF-α and IL-6 [71]. Increased body fat leads to increased 
production and release of these molecules which will cause the activation of the innate 
immune system. 
Inflammatory cytokines such as TNF-α have been reported to be significantly 
increased in diabetic rats [72]. Tumour necrosis factor (TNF-α) is a cytokine released in 
the inflammatory process. Recently, it was found out that TNF-α also plays a role in the 
early events of insulin transmembrane signalling [73]. During the insulin pathway, both the 
insulin receptor j3-subunit and IRS-1 (its major cytosolic substrate) are phosphorylated by 
an insulin-induced tyrosine cascade [56, 57]. High concentrations of TNF-α decrease the 
insulin-stimulated auto phosphorylation of the insulin receptor and the phosphorylation of 
IRS-1 [73]. This can explain how insulin resistance can be related with a pro inflammatory 
state, as high concentrations of TNF-α occur in inflammatory response [71]. 
Interleukin 6 (IL-6) is another pro inflammatory cytokine whose expression is 
enhanced in the plasma and adipose tissue of obese insulin-resistant subjects [70]. It is 
produced in many inflammatory cells, adipocytes, muscular cells and pancreatic β-cells 
[72]. It can be responsible for inducing insulin resistance in adipocyte tissue and liver, and 
may act along with other pro inflammatory cytokines to produce β-cell damage. It can also 
have a modulatory effect in fat tissue and genetic variances in the genes encoding to this 
protein being related with the development of diabetes [122]. High concentrations of this 
cytokine are related to an inflammatory state. 
 
4.6. In vivo animal model of type 2 diabetes 
Rats are the most commonly used vertebrate species; they are popular because of 
their availability, size, low cost, ease of handling, and fast reproduction rate [74]. One of 
the most used animals in the animal experimentation is the Wistar rat, commonly known as 
the albino rat.  
The Wistar rat is a breed from the albino rats and was developed by the Wistar 
Institute  to be used in research as a model organism. These rats are characterized by 
having white pelage and red eyes, a wide head with long ears, and a tail that has less in 
length than the length of the animal’s body. Because they share 99% of their genes with 
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humans, they are widely considered to be the prime model of inherited human disease  
[74].  
In laboratory rats, diabetes can be induced by the injection of streptozotocin, so 
this disease can be studied in an animal model. This chemical is toxic and has the ability to 
destroy the β-cells of the pancreas, which are responsible for producing insulin. In medical 
research it is used to induce diabetes in order to produce an animal model for diabetes. A 
single large dose is used to induce type 1 diabetes and multiple low doses are used to 
induce type 2 diabetes [75].  
Other studies suggest that a combination of high-fat feeding (were 40% of calories 
come from fat) and low dose of STZ injection/ multiple low doses of STZ injection can be 
effectively used in order to mimic type 2 diabetes in rats [76, 77]. This rat model will 
mimic the physical and metabolic characteristic of type 2 diabetic humans: increased body 
fat, hyperglycaemia, high fatty acid profile although being non-insulin dependent.  
Feeding rats with a high-fat diet can promote the development of hyperglycaemia 
and insulin resistance. High dose injections of STZ (single shot of 80 mg/kg), can critically 
damage pancreas resulting in compromised β-cell functioning which leads to deficient or 
no insulin secretion. This secretion can be so low that it resembles more type 1 diabetes. 
On the other hand, multiple low-dose injections of STZ (pe. 30mg/kg at weekly intervals 
for 2 weeks) do not have such arch effect and induce a gradual decrease of insulin 
secretion, which is exactly what happens in humans with a natural progression of type 2 
diabetes [78]. Thus, high-fat diet and multiple low doses of streptozotocin causes high 
blood glucose levels and low insulin concentrations symptoms that are consistent with the 
features of type 2 diabetes in humans [76, 77]. By developing a stable type 2 diabetic rat 
model it can be possible to securely evaluate the antidiabetic potential of plant materials 
administered orally.  
Rodent semi-purified diets can be obtained following the AIN-93M 
recommendations [79]. High-fat diets are obtained from basal AIN-93M purified diets 
being are prepared using the same method and recommendations as the AIN-93M diet. 
With the only different being that 40% of the diet’s caloric intake comes from fat, they are 
obtained by the replacement of wheat starch by lard (fat 15% and soybean oil 10%). These 
diets can be obtained by the mixing of common ingredients such as casein (14%), soybean 
oil (10%), wheat starch (46.5%), lard (10%), sucrose (10%), potato starch (5%). Vitamin 
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mix AIN-93M (1%) and mineral mix AIN-93M (3.5%) are also added in order to assure 
the animal’s correct intake of these essential nutrients [79]. 
 
5. Framework and aims of this master thesis 
Arbutus unedo L. is a shrub widely distributed in the Mediterranean regions, 
namely in Portugal, where it can be found mostly in the southern region. There is not much 
information available on this species. The fruit’s chemical characteristics are relatively 
well-known. As far as the leaves are concerned, not much is known about their chemical 
properties (or at least they are not so well studied as the fruits). A vast amount of biological 
effects were attributed to A. unedo, as there are many epidemiological studies about the 
shrub’s applicability in the treatment of gastrointestinal and urological problems, 
hypertension and cardiac diseases, diabetes and how this plant has anti-inflammatory, anti-
microbiological and lipid oxidation inhibitory properties. Works regarding the biological 
activities of Arbutus unedo L., most of the times use the entire plant or only roots and 
leaves as well as selected types of extracts. 
Diabetes is an epidemic disease that affects deeply the body homeostasis. Besides 
high blood glucose, high concentration of lipids and insulin resistance it can affect 
numerous other parameters. It has consequences in other body organs namely in terms of 
mineral homeostasis. Zinc, copper and calcium homeostasis has been reported to be 
disturbed in various body tissues. As diabetes can itself cause an inflammatory status, the 
expression and release of inflammatory factors and cytokines is also affected. This 
inflammatory status is also thought to disrupt insulin signalizing cascade and glucose 
transporters translocation. 
Even though Arbutus unedo L. is used in folk medicine against diabetes, the only 
work that has been done on this topic only uses roots’ aqueous extract. A study on the 
antidiabetic effects of Arbutus unedo L. leaves and fruits is of great interest. In this way, it 
will be possible to value A. unedo and to let the population know more about this endemic 
species. This can also help in the valorisation of strawberry tree fruit and can be the 
starting point of the development of new food products and supplements that use this fruit 
to promote human health. 
So, the specific aims of this study are to: 
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- Establish optimal extraction parameters to obtain Arbutus unedo L. fruits 
aqueous extracts; 
- Characterize extracts from Arbutus unedo L. berries and leaves in terms of 
the total phenolic content; 
- Evaluate, in vivo, on an animal model of type 2 diabetes, the antidiabetic 
effects of Arbutus unedo L. aqueous extracts, in selected serum and hematological 
parameters. 
- Evaluate, in vivo, on an animal model of type 2 diabetes, the effects of 
Arbutus unedo L. aqueous extracts on tissular mineral homeostasis 
- Evaluate, in vivo, on an animal model of type 2 diabetes, how Arbutus 
unedo L. aqueous extracts affects the expression of key genes related with inflammation 
and glucose metabolism, namely encoding genes for TNF-α, IRS-2, IL-6, GLUT-2 and 
GLUT-4. 
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CHAPTER II - Material and Methods 
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1.  Samples 
The leaves and fruits of Arbutus unedo L. were collected in the 24
th
 of October 
2014, in S. Pedro de Alva (Penacova, centre region of Portugal). Plant materials were 
randomly collected from adult wild plants that grew freely in the woods. Only fruits at the 
ripe stage (with red yellowish colour, not being fully ripped) and healthy fresh adult leaves 
were selected. The samples were immediately frozen and freeze dried prior to extraction. 
 
2. Preparation of extracts from Arbutus unedo L. fruits and leaves 
2.1. Selection of optimal extraction parameters to obtain extracts from Arbutus 
unedo L. fruits  
The procedure was performed according to Malheiro et al. with some adaptations 
and testing different conditions [8, 39, 42, 49, 50, 80]. 
Briefly, the fruits were crushed and powdered and 5g of powdered fruit were 
extracted with different solvents, during different extracting periods at selected 
temperatures as showed in table 4. The extracts were filtered under vacuum (glass Büchner 
funnel with nº 2 pore), evaporated under vacuum (rotary evaporator) and the resulting 
concentrated extracts were finally lyophilized. For each condition, three samples were 
obtained. 
 
Table 4: Extraction optimal parameters tested to obtain extracts from Arbutus unedo L. 
fruits. 
Assay Extraction 
time 
Solvents Temperature of 
extraction 
Mass/Volume 
Ratio 
Reference(s) 
1 45min Water 100ºC 5g/250mL [8, 39] 
2 45min Water 90ºC 5g/250mL [8, 39] 
3 45min Water 80ºC 5g/250mL [8, 39] 
4 60min Water 90ºC 5g/250mL [49, 50] 
5 120min Water 90ºC 5g/250mL [49, 50] 
6 45min Water 90ºC 5g/125mL [42] 
7 45min Water 90ºC 5g/62.5mL [42] 
8 45min Ethanol 50% 63ºC 5g/250mL [80] 
 
On assay 8, the selected temperature was 63ºC, due to the fact that the extraction 
was made with Ethanol 50%. This temperature was used in a previous work using the same 
solvent to obtain a plant aqueous extract, suitable to test in vivo [80].  
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2.2. Extraction conditions used to obtain the Arbutus unedo L. leaf extract 
The procedure was performed according to the procedure described by Malheiro 
et al. [8]. Briefly, the dried leaves were powdered with a food processor and 5g of 
powdered leaves were extracted with 250 mL of water at 100ºC for 45 min. The extracts 
were filtered under vacuum (glass Büchner funnel with nº 2 pore), evaporated under 
vacuum (rotary evaporator) and the resulting concentrated extracts were finally 
lyophilized. 
 
2.3. Total Phenolic Determination 
Total phenolic Concentration (TPC) was determined using the Folin-Ciocalteu 
method as described by Singleton [81].  The method consists in the addition of 500 μL of 
distilled water to 125 μL of the diluted sample. For each extract, a mother sample was 
prepared by dilution of 50mg of extract in 10mL of solvent (methanol:water). For leaves 
extract, 1:2, 1:4 and 1:16 solutions were prepared. In order to fit the calibration curve, in 
this analysis, only the 1:16 (0.3125 mg in 10 mL of solvent) dilution was used. To this 
mixture, 125 μL of Folin-Ciocalteu reagent was added and the mixture was kept in the dark 
for 5 minutes. After, 1.25 mL of Na2CO3 in the concentration of 75 g/L and 1 mL of 
distilled water are added. The solutions were kept in the dark again for 60 min and then the 
absorbance was measured at λ=760 nm in a 6405 UV/Vis Jenway Spectrometer. The blank 
was prepared by replacing the volume of the sample by distilled water. 
Previously, a calibration curve was performed using gallic acid as standard. For 
this calibration curve, various solutions of gallic acid were prepared in concentrations of 
61.995, 123.99, 186, 248 and 310 mg/L. The calibration curve was given by the A760 
against the concentration of gallic acid. All the measurements were made in triplicate, 
using three aliquots of each extract and the average value was calculated in each case. The 
A760 of the blank was subtracted to each sample A760. The results were expressed as mg of 
GAE per 100 g of extract. 
 
The optimal extraction parameters to obtain the fruit extract were established by 
combining the best extraction yield with the highest total phenolic concentration. 
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3. Evaluation of the impact of Arbutus unedo L. extracts intake in a rat model of type 
2 diabetes 
In order to evaluate the in vivo properties of Arbutus unedo L., a trial was 
performed. The doses given orally were: 1.25 and 0.5 g/kg b.w. per day of fruit and leaf 
extracts respectively. 
 
3.1. Diets 
Arbutus unedo L. fruit’s extract were found to be a very hydroscopic material. 
Thereby, in order to mix it with the diet the extract was previously mixed in 16.7% of 
maltodextrin. Briefly, 339 g of extract were mixed with 67.80g of Maltodextrin in warm 
(70ºC) water, according to the ratio of 2g of Maltodextrin: 10g of crude (sticky) extract: 
5mL of distilled water. The samples were then freeze dried at 50ºC.  
Four types of diets were prepared for this experiment: the control diet which was 
prepared according to AIN- 93M rodent diets recommendations [79], a high-fat diet on 
which 40% of the energy was provided by fat  and high-fat diet mixed with each of the 
plant extracts. The control diets were prepared by mixing casein (14%), soybean oil (10%), 
wheat starch (56.5%), sucrose (10%), potato starch (5%), vitamin mix AIN-93M (1%) and 
mineral mix AIN-93M (3.5%). High-fat diets were prepared using the same method and 
recommendations as the AIN-93M diet, the only difference being the replacement of wheat 
starch by lard (fat), thereby being composed finally by casein (14%), soybean oil (10%), 
wheat starch (46.5%), lard (10%), sucrose (10%), potato starch (5%), vitamin mix AIN-
93M (1%) and mineral mix AIN-93M (3.5%). In order to obtain the plant enriched diets, 
normal high-fat AIN-93M diets were prepared the only difference being the replacement of 
12% and 7% of wheat starch by 12% and 7% of fruit extract and leaves extract in case of 
High-Fat Fruit Extract diet and High-Fat Leaf Extract diet respectively. The amount of 
extracts were different in order to fit the doses of 1.25g/kg b.w. of fruit extract and 0.5g/kg 
b.w. of leaves extract, as determined by the total amount of available materials. The diets 
were prepared weekly and stored at 4ºC in plastic tupperwares until use. Figure 4 illustrates 
the consistency of the high-fat diet. 
Table 5 summarizes the composition of the experimental diets used in both trials 
of this experiment. Table 6 gives the composition of both mineral and vitamin mix. 
 
34 
 
Table 5: Composition of Control, High-Fat and High-Fat plant extract diets. 
Ingredient 
(g/kg) 
Diets 
 C HF HF+FE HF+LE 
Casein  140 140 140 140 
Sunflower oil  100 100 100 100 
Lard  0 100 100 100 
Wheat starch  565 465 453 458 
Sucrose  100 100 100 100 
Potato starch  50 50 50 50 
Mineral Mix  35 35 35 35 
Vitamin Mix  10 10 10 10 
Plant Extract  - - 12 7 
Abbreviations: HF- High Fat; HF+FE-high fat with fruit extract (1.25g/kg); HF-LE- high-fat with 
leaf extract (0.5g/kg) 
 
 
Figure 4: Two male Wistar rats used in the trial fed with the AIN- 93M derived high-fat 
diet. Note consistency of the diet. 
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Table 6: Composition of AIN-93M vitamin and mineral mix, adapted from Reeves et al. 
[79]. 
Vitamin  
g/kg mix 
Mineral  
g/kg mix 
Nicotinic acid 3 Calcium 5000 
Ca Pantothenate 1.6 Phosphorus 1992 
Pyridoxine-HCL 0.7 Potassium 3600 
Thiamin-HCL 0.6 Sulphur 300 
Riboflavin 0.6 Sodium 1019 
Folic acid 0.2 Chloride 1571 
D-Biotin 0.02 Magnesium 507 
Vitamin B-12 2.5 Iron 35 
Vitamin E 15 Zinc 30 
Vitamin A 0.8 Manganese 10 
Vitamin D3 0.250 Copper 6 
Vitamin K 0.075 Iodine 0.2 
 Molybdenum 0.15 
Selenium 0.15 
Silicon 5 
Chromium 1 
Fluoride 1 
Nickel 0.5 
Boron 0.5 
Lithium 0.1 
Vanadium 0.1 
 
 
3.2. Animals, diets and experimental protocol 
Male adult Wistar rats (n = 28, 11 weeks old) were purchased from the Licensed 
Laboratory of the Animal Breeding Centre (Poznan, Poland). After arrival at the animal 
care facility, rats were kept under controlled temperature (21 ± 2ºC) and humidity (55-
60%) with a 12h/12h day/night cycle throughout the experiment. After a 5 day adaptation 
period, animals were divided into 4 groups (of 7 rats each, initial mean body weight = 330 
g), and kept in metal-free individual cages with 2 rats per cage (Figure 5). The control 
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group was fed the AIN-93 M standard diet, while 3 groups received high-fat diet (HF) for 
2 weeks. 
 
Figure 5: Allocation of the Wistar rats throughout the experiment (kept in metal-free 
individual cages containing 2 rats each). 
  
The AIN-93M and HF diets were prepared according to the AIN-93M 
recommendations, with slight modifications [79]. AIN-93 (control group) was composed 
by casein (14%), sunflower oil (10%), wheat starch (56.5%), sucrose (10%), potato starch 
(5%), vitamin mix AIN-93 M (1%) and mineral mix AIN-93 M (3.5%). While, the HF 
diets (40% calories from fat) were obtained from the basal AIN-93 diet, by replacement of 
wheat starch with fat (lard 15% and sunflower oil 10%), being thereby composed by casein 
(14%), sunflower oil (10%), wheat starch (46.5%), lard (10%), sucrose (10%), potato 
starch (5%), vitamin mix AIN-93M (1%) and mineral mix AIN-93M (3.5%). Diets were 
prepared weekly and stored in sealed containers at 4 ± 1 °C. Food intake was measured 
daily and body mass every 7 days. 
 After 2 weeks of HF diet feeding, rats were subjected to multiple intraperitoneal 
injection of STZ freshly dissolved in 0.1 M-citrate buffer (pH 4.4), given in 3 subsequent 
doses: 20, 10 and 25 mg/kg body weight, in weekly intervals, while rats of the control 
group were injected in the same manner, but with the carrier alone (citrate buffer). The 
approach with multiple doses of STZ has been shown to be more efficient in producing 
diabetes in rat [78]. Finally, presence of diabetes (DB) in rats was confirmed by measuring 
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fasting blood glucose concentration in blood samples (> 11 mmol/l) withdrawn from the 
tail tip after 48 h using a glucometer (iXell®, Genexo, Warsaw, Poland).  
Thus, the four experimental groups were, as follows: (1) no-DB/not treated n=5 
(fed control diet); (2) DB/not treated (fed HF diet) n=8; (3) DB/FE, 1.25g/kg b.w./day fed
 
HF diet (HF + FE) n=6; (4) DB/LE, 0.5g/kg  fed HF diet (HF + LE) n=6. The doses were 
based on the available amount the materials. 
After 4 weeks of feeding and overnight fast, the animals were anesthetized with 
CO2 inhalation and dissected to collect blood and the internal organs. Blood samples were 
drawn from the heart aorta into Vacutest tubes with plasma coagulant (Medlab-Products, 
Raszyn, Poland), coagulated at room temperature for 20 min, and centrifuged at 4000 rpm. 
Internal organs (liver, kidneys, heart, spleen, pancreas, testes) and both femoral bones were 
removed for further analysis. Organs were washed in saline (0.9% NaCl), weighed and 
stored at -20°C until analysis. Serum samples were separated and kept in aliquots at −70 
°C for biochemical assays. 
 All animal procedures and the protocol were conducted according to EU 
Directive 2010/63/EU for animal experiments and approved by the Local Animal Bioethics 
Committee in Poznan, Poland (No 3/2015). All necessary efforts were made to minimize 
the number of animals used and their suffering. 
 
3.3. Analytical methods 
3.3.1 Blood indices  
Blood (whole and serum) analyses were conducted in a certified laboratory 
(Laboratorium Medvczne Synevo, Poznan).  
Analysis for the insulin levels, HOMA-IR and gene expression took place in 
Uniwersytet Przyrodniczy w Poznaniu although they were not executed entirely by me. 
Another investigator working on this in vivo experiment kindly performed the analysis and 
supplied the results. 
 
a) Blood hematological indices 
Blood haematological indices, as given below, were determined by appropriate 
analytical methods, as follows.  Blood haemoglobin (Hb) level was determined by the 
Drabkin cyanohemoglobin method  [82]. Red Blood Cell Count (RBC), Haematocrit 
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(HCT), Mean Corpuscular Volume (MCV), Mean Corpuscular Haemoglobin (MCH),  
Mean Corpuscular Haemoglobin Concentration (MCHC),  White Blood Cell Count 
(WBC),  Platelets (PLT),  Platelet Distribution Width (PDW),  Mean Platelet Volume 
(MPV),  Platelet Large-Cell Ratio (P-LCR) and  Red Cell Distribution Width Based On 
Standard Deviation (RDW-SD)  were all were obtained using the  CELLDYN-1700 
analytical haematology system.   
  
b) Blood biochemical indices 
Blood biochemical indices, as given below, were determined by appropriate 
analytical methods, as follows: serum glucose concentration by the hexokinase method 
[83]; total cholesterol, HDL cholesterol and TAG concentrations were determined using  
enzymatic methods while LDL cholesterol concentration was given by the calculation 
method  [84-86];  urea concentration by the urease and glutamine dehydrogenase method 
[87]. 
The activity of the enzymes ALT, AST and ALP was measured using kinetic 
method with NADH and TRIS buffer [88]. Serum creatinine concentration was also 
determined by a kinetic method using picric acid [87] while the total protein concentration 
was measured by a colorimetric method using Cu
2+
 ions [86]. 
The C-reactive protein was also measured by a immunoturbidimetric method 
performed using a COBAS INTEGRA analyzer (Roche Diagnostics),  were the C-reactive 
protein agglutinates with latex particles coated with monoclonal antiCRP antibodies and 
the resulting aggregates are quantified turbidimetrically [89]. 
 The Serum Fe concentration was determined by the Guanidine/Iron-Zine method 
were by the action of guanidine cloridrate the Fe(III) is released from transferrin and 
reduced to Fe(II) which will kelate with IronZine and form a reddish complex that can be 
quantified by absorbance [90, 91]. 
Insulin was measured by a specific RIA kit for rats (Linco) according to the 
procedure by Cacho et al. [92]. 
Finally, the Insulin resistance was characterized by the homeostasis model 
assessment (HOMA) indices using the equation given below [92, 93]: 
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3.3.2. Microelements (Fe, Zn, Cu) status in tissues 
Firstly, a small slice of each tissue has collected into an Eppendorf and kept at 
105ºC for 2 days in order to determine the dry mass of the tissue. After, 1g of the different 
tissues were weighted and collected into Teflon vessels (MARS-5) and digested in 65% 
(w/w) of HNO3 (GR ISO). The vessels were placed inside the microwave oven 
(Microwave Digestion System (MARS 5, CEM)) according to each tissue’s selected 
program. The clear mineralized samples were transferred quantitatively to a volumetric 
25mL polypropylene flask and the volume was filled with high-grade deionized water. The 
mineralized was then transferred to clean (25-50 mL) polypropylene bottles.  
Thereafter, the concentrations of Fe, Zn and Cu in the mineral solutions were 
measured by the flame atomic-absorption spectrometry (F-AAS) method (AAS-3 
spectrometer, Zeiss, with BC, Germany). The accuracy of quantitative determinations of 
Fe, Zn and Cu was assured by simultaneous analyses of the certified reference material 
(Pig Kidney BCR® No. 186, Brussels), with the recovery of: 98.6%, 97.5% and 98.4%, 
respectively. 
 
3.3.3. Gene Expression by Relative real-time PCR 
Total RNA from rats’ liver, muscle and fat tissue was isolated using the tripure 
isolation kit according to the manufacturer’s protocol (Roche diagnostic, Germany). The 
quantity and quality of RNA was determined by 260/230 nm and 280/260 nm absorbance 
ratios using a NanoDrop 2000 spectrometer (Thermo Scientific, USA). After RNA 
isolation, a total of 1 μg RNA was used to perform the reverse transcription (RT). RT was 
executed using a Transcriptor First Strand cDNA Synthesis Kit (Roche diagnostic, 
Germany), using a combination of anchored-oligo(dT)18 and random hexamer priming, 
being performed at 25 ºC for 10 min, followed by 1h at 50°C and finally the inactivation of 
RT enzyme was performed for 5 minutes at 85°C. cDNA quantity and quality were also 
assessed using a NanoDrop 2000 spectrometer (Thermo Scientific, USA). cDNA was 
stored at 4ºC until analysis (up to 2 weeks). 
Real-time PCR was performed with gene-specific intron spanning primers. Each 
real-time PCR reaction (n=4) containing Light-Cycler Fast Start DNA Master SYBR 
Green I and 3 μL of diluted cDNA in a total volume of 10μl was carried out using 
QuantStudio™ 12K Flex Real-Time PCR System (Thermo Fisher Scientific, USA). Real 
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time PCR was performed under the following conditions; 45 cycles during 10 minutes at 
95°C for pre-incubation, then 10 seconds at 95°C for denaturation and 7 seconds at 60°C 
for annealing and extension, further, the melting curve consisted on 15 s at 95ºC and 60ºC, 
1min. The specificity of PCR products was monitored on the basis of melting curve 
analysis.  
Genes’ expression was measured by a comparative CT method (ΔΔCT) real time 
PCR GAPHD expression was used as an internal control. Before using the ΔΔCT method 
for quantitation, a validation experiment was performed for primer efficiency investigation. 
 
3.3.4. Statistical analyses 
All the results are presented as means ± standard deviation. Normality of 
distribution of data was verified by the Shapiro–Wilk test. Significance of differences of 
means was calculated using, one-way analysis of variance (ANOVA) followed by a 
multiple comparison test (Tukey’s HSD) Means were considered statistically different at p 
< 0.05. All calculations were made using the software GraphPad Prism version 6 for 
Windows (trial version, GraphPadSoftware, San Diego California, USA). 
The graphics presented in “Chapter III – Results” illustrate results that differ 
statistically (with exception to figure 29). The graphics presented in Appendix 2 illustrate 
the results that do not differ statistically (with exception to figure 59) 
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1. Extraction yields obtained for Arbutus unedo L. fruit aqueous extract (with 
different extraction  conditions) and Arbutus unedo L. leaf aqueous extract 
By testing the different extraction conditions in order to obtain the A. unedo fruit 
extract, different extraction yields were obtained. The obtained yields, as well as the 
extraction yield for the different tested conditions, are showed in Table 7.  
 
Table 7: Yield, extraction yield (Mean ± SD) of Arbutus unedo L. fruit extracts obtained 
for each of the different conditions tested. 
Condition tested Extraction method Yield (g) Extraction yield (% 
w/w) 
Temperature 
- 45min 
- 5g/250mL 
- water 
100ºC 
 
 
3.10 58.5 ± 6.7 
 2.55 
3.17 
90ºC 
 
3.93 78.4 ± 1.0 
 3.96 
3.98 
80ºC 
 
3.81 73.5 ± 5.1 
3.90 
3.45 
Time 
- 90º C 
- 5g/250mL 
- water 
 
 
45 min 
 
3.93 78.4 ± 1.0 
 3.96 
3.98 
60min 
 
3.12 57.1 ± 3.9 
 2.79 
2.76 
120min 
 
3.09 59.5 ± 2.4 
2.89 
3.06 
Mass/Volume Ratio 
- 90º C 
- 45 min 
- water 
 
5g/250mL 
 
3.93 78.4 ± 1.0 
 3.96 
3.98 
5g/125 mL 
 
3.09 56.0 ± 5.3 
 2.87 
2.54 
5g/62,5 mL 
 
3.12 60.4 ± 3.4 
2.88 
3.14 
Solvents 
- 90º C 
- 63º C* 
- 45 min 
- 5g/250mL 
 
Water 
 
 
3.93 78.4 ± 1.0 
 3.96 
3.98 
Ethanol 50%* 
 
3.36 61.6 ± 7.6 
2.66 
3.28 
* for the extraction with Ethanol 50%, the extraction temperature was 63ºC. 
 
There was no opportunity to test different extraction conditions in order to obtain 
the Arbutus unedo L. leaves aqueous extract. Consequently, the extract was obtained by 
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following the procedure developed by Malheiro et al. [8]. The extractions yields obtained 
by these conditions are shown in Table 8. 
 
Table 8: Yields and extraction yield (Mean ± SD) of Arbutus unedo L. leaf aqueous 
extracts. 
Extracting Conditions Yield (g) Extraction yield (% w/w) 
100ºC, 45min, 5g of leaves for 
250mL of water 
1.602 
31.80  ± 0.23 1.613 
1.623 
 
2. Total Phenolic Determination 
The total amount of phenols was also measured according to the Folin-Ciocalteu 
method [81], expressed in GAE. Same procedure was performed in leaves aqueous extract 
and in the fruits aqueous extracts obtain by different extraction conditions. 
After, the graphic of the A760 against the concentration of gallic acid was plotted 
and the calibration curve was obtained. Table 16 of Appendix 1 presents the A760 obtained 
for different concentrations of gallic acid (in triplicate). This calibration curve is illustrated 
in figure 6; analysing this figure, we can see that the calibration curve presents a 
correlation of 0.9902 and linearity in the concentration ranges of gallic acid. 
 
 
Figure 6: Calibration curve of gallic acid 
The results obtain for each extract are shown in table 9. 
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Table 9: Total phenolic content of Arbutus unedo L. fruits and leaves aqueous extracts 
(Mean ± SD). 
 Assay Extraction conditions Total phenols (mg GAE/g of 
extract) * 
Fruit 1 100ºC 45 min 5g/250mL water 2.41 ± 0.03 
2 90ºC 45 min 5g/250mL water 2.52 ± 0.07 
3 80ºC 45 min 5g/250mL water 2.12 ± 0.06 
4 90ºC  60min 5g/250mL water 1.94 ± 0.10 
5 90ºC 120min 5g/250mL water 2.12 ± 0.17 
6 90ºC 45 min 5g/125mL water 2.35 ± 0.17 
7 90ºC 45 min 5g/62.5mL water 1.74 ± 0.04 
8 63ºC 45 min 5g/250mL Ethanol 50% 2.80 ± 0.25 
Leaf 9 100ºC 45 min 5g/250mL water 24.45 ± 1.31 
*n=3 replicates from each extract 
According to table 10, the best extraction conditions to obtain the highest TPC 
were: 5 grams of fruit powder in 250 mL of Ethanol (50% v/v) at 63ºC during 45 
minutes; and 5 grams of fruit powder in 250 mL of water at 90ºC during 45 minutes.  
 
3. Evaluation of the impact of Arbutus unedo L. extracts intake in a rat model of type 
2 diabetes 
The effect of feeding rats with the high-fat diets, followed by a STZ injection and 
treatment with high-fat diet containing Arbutus unedo L. leaf aqueous extract (AUL) and 
fruit aqueous extract (AUF) in overall growth and organ indices in rats is given in Table 10. 
It can be seen that there is no significant difference in food intake in the four experimental 
groups. There was no influence of the tested extracts in this parameter (graphic in 
Appendix 2). 
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Table 10:  Effect of high-fat diets/STZ injection and Arbutus unedo L. leaf and fruit 
aqueous extract in overall growth and organ indices in rats (mean ± SD) 
Index Experimental group 
No-Diabetes/Control Diabetes/No-
treatment 
AUL AUF 
Food intake (g day 
-1
) 20.09 ± 1.46 20.89 ± 1.76 20.27 ± 2.57 20.36 ± 3.40 
Body mass gain (g) 39.4 ± 4.39
b
 -0.5 ± 15.68
a
 7.83 ± 19.99
a
 5.17 ± 28.24
a
 
Relative body mass gain (%) 9.78 ± 1.11
b
 -0.28 ± 3.75
a
 1.89 ± 4.93
a,b
 1.68 ± 8.04
a,b
 
Body mass/ body length g cm 
-1
) 16.7 ± 1.3
b
 14.7 ± 1.3
a,b
 13.7 ± 1.3
a
 14.6 ± 2.1
a,b
 
Liver (% b.m.) 3.04 ± 0.24 3.38 ± 0.32 3.24 ± 0.10 3.64 ± 0.54 
Kidneys (% b.m.) 0.60 ± 0.04a 0.85 ± 0.11b 0.80 ± 0.11b 0.829 ± 0.202b 
Spleen (% b.m.) 0.15 ± 0.03 0.15 ± 0.02 0.14 ± 0.01 0.16 ± 0.03 
Heart (% b.m.) 0.28 ± 0.02 0.29 ± 0.03 0.29 ± 0.03 0.30 ± 0.06 
Testes (% b.m.) 0.93 ± 0.04 0.97 ± 0.07 0.98 ± 0.08 0.77 ± 0.42 
Pancreas (% b.m.) 0.24 ± 0.04 0.26 ± 0.02 0.25 ± 0.02 0.25 ± 0.07 
Left Femur bone (% b.m.) 0.21 ± 0.02 0.24 ± 0.02 0.25 ± 0.03 0.24 ± 0.05 
Right Femur bone (% b.m.) 0.22 ± 0.01 0.25 ± 0.01 0.25 ± 0.02 0.24 ± 0.05 
Abbreviations: b.m. – body mass, AUL – high-fat diet with Arbutus unedo L. aqueous Leaf Extract (0.5 
g/kg)/STZ injected, AUF – high-fat diet with Arbutus unedo L. aqueous Fruit Extract (1.25g/kg)/STZ 
injected. Means on same line without common superscript differ significantly (p < 0.05). 
 
When comparing the experimental groups in terms of body mass gain, it can be 
seen that the high-fat feeding along with the STZ injection resulted in a significant (p < 
0.05) decrease on the body mass gain and  relative body mass gain (expressed as % of the 
initial body mass) when compared with the control (Figure 7 and 8). This effect is mostly 
pronounced in the high-fat diabetic control group. The groups that were fed with A. unedo 
aqueous extracts in the high-fat diet had an increased body mass gain when compared with 
the diabetic group although this was not considered statistically significant (p > 0.05). 
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Figure 7:  Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in body mass 
gain (g). Bars with SD bars without common superscript differ significantly (p < 0.05). 
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Figure 8: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in relative 
body mass gain (%). Bars with SD bars without common superscript differ significantly 
(p < 0.05). 
 
 
Other growth indices were also determined. The high-fat feeding combined with 
the STZ injection appeared to slightly affect the body mass/ body length ration of the 
animals which is consistent with the decreased body mass gain presented during the 
experiment (Figure 9). This effect was greater in the AUL group as this group had a slightly 
higher body mass gain. The high-fat diets also had a significant effect (p < 0.05) on the 
rat’s relative kidney mass (expressed as % of body weight) as the diabetic control group 
along with the A. unedo supplemented groups had an increased kidney mass (Figure 10). 
Other tissues as liver, spleen, heart, testes, pancreas and femur bones were not affected by 
the high-fat diets and STZ injection in terms of relative mass (graphics in Appendix 2). 
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Figure 9: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in body mass/ 
body length ratio (g cm 
-1
). Bars with SD bars without common superscript differ 
significantly (p < 0.05). 
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Figure 10: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in kidney 
weight (% of rat’s body mass). Bars with SD bars without common superscript differ 
significantly (p < 0.05). 
 
The effect of high-fat diets, STZ injection and Arbutus unedo L. leaf and fruit 
aqueous extract in blood biochemistry parameters of rat’s serum was also one of the aims 
of this work. Table 11 summarizes how these conditions affected serum carbohydrates 
levels, serum lipid indices and toxicity biomarkers. Rats which were injected with STZ and 
fed with a high-fat diet presented a significant (p < 0.05) elevated blood glucose 
concentration, serum urea concentration and serum creatinine concentration (Figure 11, 12 
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and 13). In the A. unedo supplemented groups, the creatinine concentration was not as high 
as in the diabetic not treated group. Total cholesterol, triacylglycerols levels, HDL 
cholesterol and LDL cholesterol levels were not significantly affected (Appendix 2). The 
increased glucose concentration is a metabolic change directly related with diabetes 
mellitus. These diabetic not-treated groups of rats also had an increased insulin resistance 
(HOMA-IR) index (p < 0.05). The diabetic rats also presented higher insulin levels but this 
change was not as high as initially expected and these levels are similar to the ones of the 
control group.  
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Figure 11: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum 
glucose levels (mmol dm 
-3
). Bars with SD bars without common superscript differ 
significantly (p < 0.05). 
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Table 11: Effect of high-fat diets, STZ injection and Arbutus unedo L. leaf and fruit aqueous extracts in blood biochemistry parameters of 
rats’ serum (mean ± SD). 
Blood Parameter Experimental group    
No-Diabetes/Control Diabetes/No-treatment AUL AUF 
Glucose concentration (mmol dm 
-3
) 9.18  ± 1.38
a
 16.08 ± 4.52
b
 15.07 ± 4.18
a,b
 13.13 ± 4.04
a,b
 
Total cholesterol concentration (mg dL 
-1
) 99.34  ± 15.01 83.34 ± 17.04 87.68 ± 12.44 97.98 ± 16.14 
HDL cholesterol concentration (mg dL 
-1
) 72.80  ± 3.19 64.69 ± 13.32 79.07 ± 19.46 75.92 ± 11.41 
LDL cholesterol concentration (mg dL 
-1
) 12.43  ± 3.03 8.66 ± 3.79 8.85 ± 5.74 8.42 ± 3.73 
Triacylglycerols concentration (mg dL 
-1
) 74.63  ± 38.12 91.51 ± 60.11 57.34 ± 25.80 66.98 ± 20.65 
HOMA-IR index 13.38 ± 3.09
a
 37.71 ± 5.76
c
 16.87 ± 2.66
a,b
 22.75 ± 6.271
b
 
Insulin (mU/mL) 33.93 ± 9.36
a
 42.53 ± 18.87
a,b
 27.59 ± 6.96
a
 63.93 ± 13.80
b
 
Urea (mg dL 
-1
) 29.28  ± 2.67
a
 65.95 ± 15.70
b
 66.23 ± 21.69
b
 48.53 ± 12.96
b
 
Creatinine (mg dL 
-1
) 0.39  ± 0.06
a
 0.55 ± 0.09
b
 0.54 ± 0.12
a,b
 0.43 ± 0.08
a,b
 
ALT (U L 
-1
) 26.00  ± 10.32
a
 53.00 ± 26.38
a,b
 74.50 ± 32.87
b
 48.20 ± 14.79
a,b
 
AST (U L 
-1
) 78.00  ± 32.60 97.43 ± 18.21 112.20 ± 34.37 132.67 ± 91.81 
ALP (U L 
-1
) 60.20  ± 8.73
a
 153.14 ± 45.32
b
 124.60 ± 52.31
a,b
 127.80 ± 9.52
b
 
CRP (mg L 
-1
) 0.11  ± 0.04 0.11 ± 0.03 0.084 ± 0.03 0.132 ± 0.026 
Total Fe concentration (μg dL -1) 116.76  ± 14.75 143.11 ± 21.25 136.77 ± 15.50 128.80 ± 8.64 
Total protein concentration (g dL 
-1
) 6.86  ± 0.40 6.36 ± 0.52 6.28 ± 0.42 6.55 ± 0.47 
Abbreviations: ALT - Alanine Aminotransferase, AST - Aspartate Aminotransferase, ALP - Alkaline phosphatase, CRP - C-reactive protein, AUL – high-fat with 
Arbutus unedo L. aqueous Leaf Extract (0.5 g/kg)/STZ injected, AUF – high-fat with Arbutus unedo L. aqueous Fruit Extract (1.25g/kg)/STZ injected. Means on same 
line without common superscript differ significantly (p < 0.05).
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Figure 12: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum urea 
levels (mg dL 
-1
). Bars with SD bars without common superscript differ significantly (p < 
0.05). 
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Figure 13: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum 
creatinine levels (mg dL 
-1
). Bars with SD bars without common superscript differ 
significantly (p < 0.05). 
 
Other toxicity biomarkers were also analysed in the experimental groups’ sera. 
STZ-injected rats feed with the high-fat diets presented a significant (p < 0.05) increased 
phosphatase concentration (Figure 14). The enzyme ALT as slightly increased in the 
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diabetic not treated group and was presented in higher concentrations in the serum of A. 
unedo supplemented groups, especially the leaf aqueous extract group (Figure 15). Other 
markers as creatinine and serum urea concentration were also increased in these groups (p 
< 0.05). The administration of high-fat diets and STZ injection had no consequences in the 
AST, C-reactive protein, serum Fe levels and blood protein concentration levels (Appendix 
2). 
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Figure 14: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum 
Phosphatase levels (U L 
-1
). Bars with SD bars without common superscript differ 
significantly (p < 0.05). 
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Figure 15: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum 
ALT levels (U L 
-1
). Bars with SD bars without common superscript differ significantly (p 
< 0.05). 
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Adding Arbutus unedo L. fruit and leaf aqueous extract (in the doses of 0.5 g/kg 
b.w and 1.25 g/ kg b.w. respectly) to the high-fat diets had some effects in blood 
biochemistry and toxicity biomarkers. Two groups of rats were fed with the high-fat diet 
supplemented with these extracts and some metabolic changes were detected. When 
compared to the diabetic control group, the Arbutus unedo L. fruit and leaf aqueous 
extracts supplemented groups presented a tendency towards reducing blood glucose 
concentration to the levels presented by the non-diabetic control group. Nevertheless the 
insulin levels were increased in the Arbutus unedo L. fruit aqueous extract supplemented 
group (Figure 16), being normalized in the leaf extract supplemented group (p < 0.05). 
Both Arbutus unedo L. aqueous extract supplemented groups had an improved HOMA-IR 
index, as the insulin resistance decreased in these groups with special emphasis in leaf 
aqueous extract group which HOMA-IR index is almost the same as the control group 
(Figure 17).  
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Figure 16: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in insulin 
levels (mU mL 
-1
). Bars with SD bars without common superscript differ significantly (p < 
0.05). 
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Figure 17: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in HOMA-IR 
index. Bars with SD bars without common superscript differ significantly (p < 0.05). 
 
Urea levels (Figure 12) were higher in all the groups injected with STZ, the 
supplementation with the A. unedo aqueous extracts showed no effect (p < 0.05). 
Creatinine levels were also higher in the STZ injected groups when compared with the 
control; however in the Arbutus unedo L. fruit and leaf aqueous extract supplemented 
groups there was a tendency towards decreasing creatinine levels to controllevels. The 
inflammation marker CRP remained unchanged in all groups (data on Appendix 2). 
Surprisingly ALT serum concentration was higher in the group fed with the Arbutus unedo 
L. aqueous extract, an effect considerably higher in the leaf extract supplemented group (p 
< 0.05). Phosphatase levels were much higher in diabetic group than in control group. This 
effect was not improved in the group supplemented with Arbutus unedo L. fruit aqueous 
extracts as the serum levels of phosphatase remained high. This time the most beneficial 
effect was presented by the leaf extract group were phosphatase levels slightly decreased 
(to levels presented by the control group).  
The haematogram of the animals was also analysed mainly to reinsure that the 
animals remained healthy during all the experiment. The results can be seen in table 12. 
There were no significant changes in almost all of the tested blood morphology 
indexes (Appendix 2). On the STZ- injected/high-fat diets fed groups the platelets levels 
(PLT) were lower (Figure 18) and red cell distribution width (RDW) has higher (Figure 19 
and Figure 59 of Appendix 2). A. unedo extracts appear to have attenuated these effects as 
55 
 
there was a tendency to normalize this parameter’s levels to levels presented by the control 
group. Procalcitonin (PCT) is a peptide which is produced as a response to an 
inflammatory stimulus, namely bacterial infections [94]. On all diabetic groups (except 
AUF) this value was reduced when compared to the control (Figure 20).  
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Figure 18: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
platelets levels. Bars with SD bars without common superscript differ significantly (p < 
0.05). 
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Figure 19: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the red 
blood cell distribution width (with standard derivation). Bars with SD bars without 
common superscript differ significantly (p < 0.05). 
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Table 12: Effect of high-fat diets/STZ injection and Arbutus unedo L. leaf and fruit aqueous extract on blood morphology and hematology in rats (mean ± SD). 
Blood Index Experimental group    
No-Diabetes/Control Diabetes/No-treatment AUL AUF 
WBC (x10 
3/μL) 4.51 ± 1.04 2.80 ± 0.98 3.67 ± 1.05 4.60 ± 1.96 
RBC (x10 
6/μL) 9.42 ± 0.17 9.77 ± 0.46 9.84 ± 0.46 9.77 ± 0.32 
HGB (g/dL) 15.24 ± 0.38 15.95 ± 0.56 15.97 ± 0.99 15.83 ± 0.56 
HCT (%) 44.64 ± 1.58 46.14 ± 2.28 45.63 ± 2.67 45.63 ± 2.48 
MCV (fl) 47.39 ± 1.32 47.30 ± 2.77 46.38 ± 0.96 46.73 ± 3.11 
MCH (pg) 16.18 ± 0.23 16.40 ± 0.87 16.22 ± 0.40 16.22 ± 0.46 
MCHC (g/dL) 34.14 ± 0.55 34.71 ± 1.04 34.97 ± 0.70 34.73 ± 1.50 
PLT (x10 
3/μL) 1128.80 ± 99.15b 893.14 ± 111.67a 848.00 ± 162.17a 1020.80 ± 128.32a,b 
RDW-SD (fl) 30.68 ± 1.72a 35.45 ± 1.96b 33.20 ± 1.84a,b 33.70 ± 2.24a,b 
RDW-CV (%) 21.74 ± 0.95a 24.24 ± 1.20b 23.55 ± 0.98b 23.73 ± 0.89b 
PDW (fl) 9.10 ± 0.44 9.54 ± 0.24 9.57 ± 0.24 9.83 ± 0.83 
MPV (fl) 7.92 ± 0.2 8.11 ± 0.29 7.98 ± 0.16 8.22 ± 0.39 
P-LCR (%) 10.70 ± 1.60 11.70 ± 1.60 11.17 ± 0.94 11.86 ± 1.92 
PCT (%) 0.89 ± 0.08
b
 0.75 ± 0.06
a,b
 0.59 ± 0.09
a
 0.83 ± 0.09
b
 
NEUT(x10 
3/μL) 0.35 ± 0.10 0.25 ± 0.09 0.29 ± 0.08 0.31 ± 0.03 
LYMPH (x10 
3/μL) 3.72 ± 1.01
b
 1.92 ± 0.53
a
 2.75 ± 0.59
a,b
 2.49 ± 0.93
a,b
 
MONO(x10 
3/μL) 0.50 ± 0.11
b
 0.19 ± 0.08
a
 0.21 ± 0.07
a
 0.22 ± 0.10
a
 
EO (x10 
3/μL) 0.04 ± 0.01 0.03 ± 0.01 0.04 ± 0.01 0.03 ± 0.01 
BASO (x10 
3/μL) 0.01 ± 0.01 0.00 ± 0.00 0.01 ± 0.01 0.00 ± 0.00 
NEUT (%) 6.35 ± 4.17 11.15 ± 4.14 9.06 ± 3.13 11.38 ± 4.36 
LYMPH (%) 77.62 ± 11.57 79.97 ± 6.29 82.78 ± 4.80 81.68 ± 4.22 
MONO (%) 9.98 ± 3.06 6.44 ± 2.21 6.60 ± 2.27 6.10 ± 1.08 
EO (%) 0.94 ± 0.34 1.64 ± 0.78 1.42 ± 0.57 0.85 ± 0.21 
BASO (%) 0.92 ± 1.79 0.70 ± 1.10 0.14 ± 0.31 0.00 ± 0.00 
Abbreviations: AUL – high-fat with Arbutus unedo L. aqueous Leaf Extract (0.5 g/kg)/STZ injected, AUF – high-fat with Arbutus unedo L. aqueous Fruit Extract 
(1.25g/kg)/STZ injected. WBC - White Blood Cell Count, RBC - Red Blood Cell Count, HGB – haemoglobin, HCT - Hematocrit , MCV - Mean Corpuscular Volume, 
MCH -  Mean Corpuscular Haemoglobin , MCHC -  Mean Corpuscular Haemoglobin Concentration , PLT -  Platelets, RDW-SD - Red Cell Distribution Width Based 
on Standard Deviation, RDW-CV - Red Cell Distribution Width Based on Coefficient of Variation, PDW - Platelet Distribution Width, MPV -  Mean Platelet Volume 
, P-LCR - Platelet Large-Cell Ratio, PCT – Procalcitonin, NEUT – Neutrophils, LYMPH – Lymphocytes, MONO – Monocytes, EO – Eosinophils and  BASO – 
Basophils. Means on same line without common superscript differ significantly (p < 0.05).
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Figure 20: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
procalcitonin percentage. Bars with SD bars without common superscript differ 
significantly (p < 0.05). 
 
The high-fat feeding and STZ injection also appeared to decrease the amount of 
lymphocytes and monocytes, as all the diabetic groups had decreased levels of this white 
globes (Figure 21 and 22). In the case of lymphocytes, once more the treatment with the A. 
unedo plant materials appears to slightly increase the lymphocyte levels (to levels showed 
by the control group). 
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Figure 21: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
lymphocytes levels. Bars with SD bars without common superscript differ significantly (p 
< 0.05). 
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Figure 22: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
monocytes levels. Bars with SD bars without common superscript differ significantly (p < 
0.05). 
The tissular copper, zinc and iron levels in the rats’ organs was also measured in 
order to clarify in STZ injection, high-fat feeding and Arbutus unedo L. extracts had some 
effects on microelement homeostasis. These results are presented in table 13. In this 
experiment, there was an elevation of the kidney copper levels, kidney zinc levels and  
kidney iron levels in all diabetic groups treated and not-treated. The Arbutus unedo L. 
aqueous extracts, HF feeding and STZ injection had no impact in the microelements’ 
hepatic levels. 
In renal tissue, there was an elevation of Cu levels in the diabetic not-treated group 
(Figure 23). This effect was not attenuated by the supplementation with A. unedo leaf or 
fruit aqueous extract. 
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Table 13: Effect of high-fat diet/STZ injection and Arbutus unedo L. aqueous leaf and fruit 
extract on the tissular Cu, Zn and Fe levels in rats organs (mean ± SD). 
Index Experimental group    
No-Diabetes/Control Diabetes/No-treatment AUL AUF 
Cu (μ g-1 dry mass)     
Liver 20.08 ± 1.11  18.30 ± 2.53 17.9 ± 12.29 17.89 ± 3.30 
Kidney 
 
26.87 ± 5.60
 a
 54.29± 15.82 
b
 67.86 ± 19.39 
b
 55.42 ± 16.85 
b
 
Zn (μ g-1 dry mass)     
Liver 144.69 ± 16.78 141.48 ± 9.47 149.31 ± 48.08 159.25 ± 18.10 
Kidney 
 
94.63 ± 4.06 
a
 117.0 ± 10.8
 b
 122.47 ± 16.53
 b
 112.82 ± 16.11
a,b
 
Fe (μ g-1 dry mass)     
Liver 417.98 ± 54.08 487.06 ± 108.45 424.72 ± 93.28 473.96 ± 101.14 
Kidney 287.7 ± 10.72a 334.0 ± 23.89a,b 382.0 ± 50.76b 360.00 ± 62.39a,b 
Abbreviations: AUL – high-fat with Arbutus unedo L. aqueous Leaf Extract (0.5 g/kg)/STZ injected, AUF – 
high-fat with Arbutus unedo L. aqueous Fruit Extract (1.25g/kg)/STZ injected, Cu – Copper,  Zn – Zinc, Fe – 
Iron. Means on same line without common superscript differ significantly (p < 0.05). 
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Figure 23: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the copper 
concentration in kidney tissue (µg 
-1
 dry mass). Bars with SD bars without common 
superscript differ significantly (p < 0.05). 
 
The kidney zinc concentrations were affected by high-fat feeding and STZ 
injection (Figure 24). However in this case, no beneficial effects can be attributed to 
Arbutus unedo L. leaf aqueous extract, as no significant change between the diabetic 
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control groups and the AUL treated group was noticed (p > 0.05). However, in the case of 
the AUF group, a slight decrease in zinc renal levels towards concentrations presented by 
the control group was noticed. 
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Figure 24: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the zinc 
concentration in kidney tissue (µg 
-1
 dry mass). Bars with SD bars without common 
superscript differ significantly (p < 0.05). 
 
The combination of STZ injection and high-fat feeding appeared to have slightly 
increased the renal iron levels in all the diabetic groups (Figure 25). This increase was even 
greater in the group supplemented with Arbutus unedo L. leaf aqueous extract (p < 0.05). 
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Figure 25: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the iron 
concentration in kidney tissue (µg 
-1
 dry mass). Bars with SD bars without common 
superscript differ significantly (p < 0.05). 
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 Interestingly, no significant changes in copper, zinc or iron homeostasis in 
hepatic tissues was noticed in all experimental groups (data shown in Appendix 2).  
Lastly, the effect of the aqueous extracts from Arbutus unedo L. fruits and leaves 
on the expression of certain genes was also studied. These genes play a role in the glucose 
metabolism and/or in inflammation response, the results are shown in Table 14. It was 
analysed the expression of these genes on hepatic, muscular and fat tissues. 
TNF-α or tumour necrosis factor is a cytokine produced by macrophages in 
response to an inflammatory process and is present mainly in the acute phase reaction [95]. 
When comparing the diabetic control group with the control group an increased expression 
of this gene in the hepatic and muscular tissues can be noticed; in fat tissue no significant 
changes occurred (p < 0.05). High-fat feeding combined with STZ injection increased then 
TNF-α gene expression. 
In liver tissue, A. unedo aqueous extracts showed to have an effect on the 
expression of the gene that encodes this protein (Figure 26). In both leaf extract and fruit 
extract supplemented groups there was a significant decreased expression of this gene (p < 
0.05).  On muscular tissue there was also a significant decreased expression of TNF-α gene 
on the group fed with Arbutus unedo L. fruit extract; in the case of leaf extract the effect 
was not as strong (Figure 27). 
 6
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Table 14: Effect of high-fat diet/STZ injection and Arbutus unedo L. aqueous leaf and fruit extract on the expression of different genes (mean ± SD). 
 Gene Expression (ΔΔCT) Experimental group    
No-Diabetes/Control Diabetes/No-treatment AUL AUF 
 TNF-α      
Liver 1.0 ± 0.27
a
 34.94 ± 43.41
b
 3.41 ± 3.48
a
 3.93 ± 3.39
a
 
Muscle 1.71 ± 0.99
a,b
 16.42 ± 8.230
b
 11.76 ± 9.24
a,b
 0.61 ± 0.43
a
 
Fat tissue 1.63 ± 1.13 1.65 ± 0.58 1.40 ± 0.25 0.98 ± 0.26 
IRS-2     
Liver 1.09 ± 0.28 1.28 ± 0.17 1.24 ± 0.16 1.28 ± 0.04 
Muscle 1.51 ± 0.45 1.68 ± 0.48 1.56 ± 0.16 1.88 ± 0.22 
Fat tissue 0.74 ± 0.20
a
 1.14 ± 0.35
b
 1.28 ± 0.42
a,b
 1.22 ± 0.61
a,b
 
IL-6     
Liver 0.65 ± 0.13 1.27 ± 0.28 1.137 ± 0.38 1.01 ± 0.55 
GLUT-4     
Liver 0.66 ± 0.25 1.64 ± 1.33 0.79 ± 0.15 0.96 ± 0.31 
Muscle 0.98 ± 0.03
a
 3.04 ± 1.50
b
 1.68 ± 1.07
a,b
 3.61 ± 3.35
a,b
 
Fat tissue 6.47 ± 1.68
b
 2.67 ± 1.97
a
 1.38 ± 0.20
a
 1.14 ± 0.70
a
 
GLUT-2     
Liver 0.52 ± 0.45 1.50 ± 1.69 1.26 ± 0.57 0.74 ± 0.52 
Muscle 82.56 ± 100.03
a
 17.96 ± 14.09
a
 134.78 ± 92.88
a,b
 282.47 ± 82.89
b
 
Abbreviations: TNF-α – Tumour Necrosis Factor α, IRS-2 - Insulin Receptor Substrate 2, IL-6 – Interleukin 6, GLUT-4 – Glucose Transporter 4, GLUT-2 – Glucose 
Transporter 2, AUL– high-fat with Arbutus unedo L. aqueous Leaf Extract (0.5 g/kg)/STZ injected, AUF– high-fat with Arbutus unedo L. aqueous Fruit Extract 
(1.25g/kg)/STZ injected. Means on same line without common superscript differ significantly (p < 0.05).
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Figure 26: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of TNF alpha gene in hepatic tissue. Bars with SD bars without common 
superscript differ significantly (p < 0.05). 
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Figure 27: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of TNF alpha gene in muscular tissue. Bars with SD bars without common 
superscript differ significantly (p < 0.05). 
The IRS-2 gene encodes a protein named insulin receptor substrate 2. There was 
no significant change in the expression of this gene in hepatic and muscular tissues in all 
experimental groups (Appendix 2). In fat tissue the high-fat diabetic groups showed an 
increased expression of IRS gene in relation to control group however there was a slight 
difference between the untreated diabetic group and the A. unedo treated diabetic groups 
(Figure 28). 
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Figure 28: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of IRS gene in fat tissue. Bars with SD bars without common superscript 
differ significantly (p < 0.05). 
 
Interleukin 6 (IL-6) is an interleukin that acts as a pro-inflammatory cytokine as 
well as an anti-inflammatory myokine and is encoded by the IL6 gene [95]. In the rats´ 
muscular tissue there was no expression of this gene (data not showed) and in the fat tissue 
the data collected was not enough to have significant relevance. In hepatic tissue, when 
comparing control, diabetic and AUL groups, no difference in the expression of IL-6 can be 
noticed. On the diabetic group treated with A. unedo fruits aqueous extract, however, there 
is an increase in the expression of Interleukin 6 (Figure 29). Within this group of rats there 
were many differences in the expression of this gene, reason why the SD is so high. For 
this reason this increased expression is not statistically significant (p > 0.05). 
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Figure 29: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of IL-6 gene in hepatic tissue.  
 
When comparing the expression of GLUT-4 in muscle and fat tissues some 
differences were noticed between the experimental groups. On the hepatic tissue, there 
were no significant changes (Appendix 2). In muscular tissue there was a significant 
increased expression of GLUT-4 gene in the high-fat fed STZ-injected diabetic groups 
when compared with the control group (Figure 30). The treatment with Arbutus unedo L. 
aqueous extracts had some effect in regulating the gene’s expression to levels presented by 
the control group although they were very low. In the rat´s fat tissue there was a significant 
change in the expression of GLUT-4 gene between control group and diabetic groups. 
Nevertheless, the supplementation with A. unedo extracts had no effect in regulating the 
expression of this gene (Figure 31).   
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Figure 30: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of GLUT-4 gene in muscular tissue. Bars with SD bars without common 
superscript differ significantly (p < 0.05). 
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Figure 31: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of GLUT-4 gene in fat tissue. Bars with SD bars without common superscript 
differ significantly (p < 0.05). 
 
GLUT-2 expression was only measured in hepatic and muscular tissues as this 
glucose transporter is not specific of fat tissue. On the rats’ liver no significant changes 
between the control and diabetic treated and not treated groups was noticed (Appendix 2). 
Bigger changes in the expression of the GLUT-2 gene occurred in the muscular tissue 
(Figure 32). The control group and the diabetic not treated group had the same level of 
expression of this gene. In both Arbutus unedo L. treated groups there was an increased 
expression of this gene in relation to the diabetic and control groups though. The group 
supplemented with the A. unedo leaf extract has a slightly higher range of expression 
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compared to the control and diabetic groups. Nevertheless the group fed with the fruit 
extract has a significant higher expression of GLUT-2. 
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Figure 32: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of GLUT-2 gene in muscular tissue. Bars with SD bars without common 
superscript differ significantly (p < 0.05). 
 
Table 15 sums up all the significant effects of the treatment of high-fat STZ-
injected diabetic rats with Arbutus unedo L.  leaf and fruit extracts. Whether or not some of 
these effects are beneficial will be discussed in the next chapter. 
It is possible to see that these extracts had so beneficial effects on some of the 
biological indices tested. A mild therapeutic potential of Arbutus unedo L. extracts has 
been evidenced in this work on selected blood, haematological, tissular indices as well as 
in gene expression. In this trial, the doses tested were relatively low due to limited 
availability of the materials.   
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Table 15: Significant effects of supplementation with Arbutus unedo L. leaf and fruit aqueous extracts in HF/STZ diabetic rats (mean ± SD). 
Significant effects of Arbutus unedo L. supplementation Experimental group    
No-Diabetes/Control Diabetes/No-treatment AUL AUF 
Blood biochemistry      
Glucose concentration (mmol dm 
-3
) 9.18  ± 1.38
a
 16.08 ± 4.52
b
 15.07 ± 4.18
a,b
 13.13 ± 4.04
a,b
 
HOMA-IR index 13.38 ± 3.09
a
 37.71 ± 5.76
c
 16.87 ± 2.66
a,b
 22.75 ± 6.271
b
 
Insulin (Um/mL) 33.93 ± 9.36
a
 42.53 ± 18.87
a,b
 27.59 ± 6.96
a
 63.93 ± 13.80
b
 
Creatinine (mg dL 
-1
) 0.39  ± 0.06
a
 0.55 ± 0.09
b
 0.54 ± 0.12
a,b
 0.43 ± 0.08
a,b
 
ALP (U L 
-1
) 60.20  ± 8.73
a
 153.14 ± 45.32
b
 124.60 ± 52.31
a,b
 127.80 ± 9.52
b
 
ALT (U L 
-1
) 26.00  ± 10.32
a
 53.00 ± 26.38
a,b
 74.50 ± 32.87
b
 48.20 ± 14.79
a,b
 
Blood morphology and haematology     
PLT (x10 
3/μL) 1128.80 ± 99.15b 893.14 ± 111.67a 848.00 ± 162.17a 1020.80 ± 128.32a,b 
RDW-SD (fl) 30.68 ± 1.72
a
 35.45 ± 1.96
b
 33.20 ± 1.84
a,b
 33.70 ± 2.24
a,b
 
PCT (%) 0.89 ± 0.08
b
 0.75 ± 0.06
a,b
 0.59 ± 0.09
a
 0.83 ± 0.09
b
 
LYMPH (x10 
3/μL) 3.72 ± 1.01
b
 1.92 ± 0.53
a
 2.75 ± 0.59
a.b
 2.49 ± 0.93
a,b
 
Tissular mineral levels     
Zn kidney 94.63 ± 4.06 
a
 117.0 ± 10.8
 b
 122.47 ± 16.53
 b
 112.82 ± 16.11 
a,b
 
Gene expression      
TNF-α Liver 2.0 ± 0.27
a
 34.94 ± 43.41
b
 3.41 ± 3.48
a
 3.93 ± 3.39
a
 
TNF-α Muscle 1.71 ± 0.99
a,b
 16.42 ± 8.230
b
 11.76 ± 9.24
a,b
 0.61 ± 0.43
a
 
IRS-2 Fat tissue 0.74 ± 0.20
a
 1.14 ± 0.35
b
 1.28 ± 0.42
a,b
 1.22 ± 0.61
a,b
 
GLUT-4 Muscle 0.98 ± 0.03
a
 3.04 ± 1.50
b
 1.68 ± 1.07
a,b
 3.61 ± 3.35
a,b
 
GLUT-2 Muscle 82.56 ± 100.03
a
 17.96 ± 14.09
a
 134.78 ± 92.88
a,b
 282.47 ± 82.89
b
 
Abbreviations: ALP – Alkaline Phosphatase, ALT- Alanine Aminotransferase, PLT – platelets, RDW-SD – Red Cell Distribution Width based on Standard Derivation, PCT- Procalcitonin, LYMPH – 
Lymphocytes, Zn – Zinc, TNF-α – Tumour Necrosis Factor α, IRS-2  – Insulin Receptor Substrate 2, GLUT – Glucose Transporters, AUL– high-fat with Arbutus unedo L. aqueous Leaf Extract (0.5 g/kg)/STZ 
injected, AUF– high-fat with Arbutus unedo L. aqueous Fruit Extract (1.25g/kg)/STZ injected. Means on same line without common superscript differ significantly (p < 0.05). 
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1. Preparation of extracts from Arbutus unedo L. fruits and leaves 
1.1. Selection of optimal extraction parameters to obtain extracts from Arbutus 
unedo L. fruits  
As mentioned previously, in order to obtain the Arbutus unedo L. fruit extract the 
optimal solvents, mass-volume ratio, extraction periods and extraction temperatures were 
first optimised.  
The temperatures used for A. unedo fruit extract preparation showed different 
extractions yields which varied between 58.3 and 78.4% at 90ºC; the extraction yield 
obtained was higher (78.4%), so this temperature was selected to perform the next assays.  
Two more extraction periods were tested, 60 minutes (57.1% extraction yield) and 
120 minutes (59.5% extraction yield). None of them presented a better extraction yield 
than the one obtained in the 45 minute extraction, reason why the next assays were 
performed at 90ºC during 45 minutes. 
In this work, it was also evaluated how the mass/volume ration affected the 
extraction capacity. Two more different rations were tested (5g/125mL and 5g/62.5mL) 
and none of them gave a better extraction yield that the ratio tested according to literature 
(5g/250mL) [39]. So this ratio was not altered in the next test. 
Another solvent, Ethanol, was also tested. In order to not evaporate the solvent, a 
different temperature was used in this extraction (63ºC). Extraction yield varied between 
78.4% in the aqueous extract and 61.6% in the hydro-ethanolic extract. Once more, the 
method reported in literature gave a better extraction yield. 
The optimal solvents, mass-volume ratio, extraction periods and extraction 
temperatures were established as 5 grams of fruit powder in 250 mL of water at 90ºC 
during 45 minutes as this conditions resulted in the best extraction yield. 
The yield obtained for this extraction was 78.4% (w/w). In a research work done by 
Mendes et al. a similar procedure was performed to obtain Arbutus unedo L. fruit aqueous 
extract. However, the only experimental difference was that the extraction was performed 
at 100ºC [39]. The extraction yield obtained in their work was 39.3% which is a much 
lower value when compared to the one obtained in this work. In order to obtain the 
extraction yields, the freshly lyophilised extracts were weighted right after lyophilisation 
was concluded. After some time, the fruit extract used in this work acquired a “sticky” 
texture which suggested that some water was still present in the extract. So the 
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lyophilisation was not entirely efficient. This could have led to a somewhat over estimated 
extraction yield. 
 
1.2. Preparation of  extracts from Arbutus unedo L. leaves 
Due to lack of time to perform the same methodology in order to establish the best 
extraction conditions of the leaves, the following procedure was used: 5 grams of leaf 
powder in 250 mL of water at 100ºC during 45minutes. The extraction yield obtained 
was 31.8% , about the same value that was achieved by Mendes et al. who performed the 
same procedure [39] and obtained an extraction yield of 32%. 
 
1.3. Total Phenolic Determination 
The A. unedo fruit’s aqueous extracts appeared to have TPC content ranging from 
1.74 to 2.5 mg GAE/g of extract (table 9). The hydro-ethanolic fruit extract presented a 
slightly higher TPC of 2.8 mg GAE/g of extract, so the difference was not big. Leaves 
aqueous extract, on the other hand, showed a much higher value, of about 24.5 mg GAE/g 
of extract.  
According to this, the best extraction conditions to obtain the highest TPC were: 5 
grams of fruit powder in 250 mL of Ethanol (50% v/v) at 63ºC during 45minutes, and  
5 grams of fruit powder in 250 mL of water at 90ºC during 45minutes. These last 
conditions also proved to be good in order to obtain the highest amount of phenolic 
compounds. 
The total phenolic content measured in this work was different from the values 
obtained in previous works. According to Mendes et al. the leaves aqueous extract had a 
phenolic content of 170.3 mg GAE/g extract and fruit aqueous extract 16.7 mg GAE/g 
extract [39]. Mendes et al. used the exact same method to obtain the leaves aqueous 
extract; in the case of the fruit extract, the only difference was the extraction temperature. 
These values are much higher than the ones obtained in this thesis. Oliveira et al. have also 
performed a study on the TPC of leaf aqueous extracts from Arbutus unedo L. obtained 
using the same procedure [96]. According to this study the leaves aqueous extract had a 
TPC of 172.21mg GAE/g of extract, very similar to the content quantified by Mendes.  
Another conclusion that can be drawn is that the leaves aqueous extract has a total 
phenolic concentration about 10 times higher than the fruits aqueous extract. 
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In conclusion, the optimal solvents, mass-volume ratio, extraction periods and 
extraction temperatures were established as 5 grams of fruit powder in 250 mL of water 
at 90ºC during 45 minutes and these were used to obtain the A. unedo fruit aqueous 
extracts. These conditions resulted in the best extraction yield and TPC. 
 
2. Evaluation of the impact of Arbutus unedo L. extracts intake in a rat model of type 
2 diabetes 
After the selection of optimal parameter of extraction, the Arbutus unedo L. 
aqueous extracts were obtained and tested in vivo. Aqueous extracts obtained from fruits 
and leaves of Arbutus unedo L. were administrated to male Wistar rats for four weeks in 
the doses 1.25g /kg b.w./day 
 
in case of leaf extracts and 0.5g /kg b.w./day 
 
in case of fruit 
extract. 
Previously, it was estimated that Arbutus unedo L. fruit aqueous extract had c.a. 
2.517 mg GAE per gram of extract and Arbutus unedo L. leaf aqueous extract had c.a. 
24.450 mg GAE per gram of extract. In terms of Total Phenolic Content and considering 
the doses given orally at the animals, one can estimate that the group supplemented with 
the Arbutus unedo L. fruit aqueous extract ingested approximately 3.146 mg GAE / kg 
b.w./ day and the group supplemented with the Arbutus unedo L. leaf aqueous extract 
ingested approximately 12.225 mg GAE / kg b.w./ day. This means that the group 
supplemented with the leaf extracts ingested a dose of phenolic compounds about 4 times 
higher than the fruit extract treated group. However, this did not mean that the AUL group 
experienced more beneficial effects than the AUF group, as it will be described, in this 
chapter.  
As previously reported, leaf aqueous extract has a much higher phenolic content 
than fruit extract 170.3 mg GAE/g extract vs. 16.7 mg GAE/g extract [39]. The 
composition of both extracts, as reported in this same work, is different as more phenolic 
compounds were identified in the leaf extract. The author related the different phenolic 
content of both extracts with the different phenolic composition. Different phenolic 
compounds exist in leaf and fruit; also, the same compound can exist in different 
concentrations (tables 1 and 2). Bioactive properties of  Arbutus unedo L. aqueous extracts 
(for leaf, fruit or roots) have been associated with antioxidants and phenolic compounds by 
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several authors [11, 41, 44-48]. Besides this family of compounds not much is known 
about leaves and roots composition. Bioactivity of A. unedo leaf and fruit aqueous extract 
has been attributed to specific compounds such as galloyl derivatives [11], tannins [45], 
catechin gallate [47]. These compounds are present in the roots’ extract as well [40]. 
The Arbutus unedo L. roots’ composition has not been largely studied and once 
more, the existing studies focused only on phenolic compounds. The roots’ aqueous extract 
of A. unedo proved to have anti diabetic properties [49, 50]. No relation with the 
composition of the extract was made (in terms of phenolics or any other family of 
compounds) as the chemical composition of the extract was not studied [49, 50].  
Bioactivity of the roots’ aqueous extract was attributed, in another work, with the presence 
of compounds such as quinones, anthocyanins, anthraquinones, flavonoids and tannins 
which are also present in leaves and fruits of A. unedo [41].  
Concerning anti-diabetic potential, the studies available in the literature only took 
in consideration the plasma glucose lowering effect [49], or performed testes like Oral 
glucose Tolerance Test (OGTT) and Intravenous Glucose Tolerance Test (IVGTT) in order 
to evaluate this property [50]. However, diabetes is a metabolic disease, which affects a lot 
more biological parameters. Taking in consideration this two works by Bnouham et al., 
physiological characteristics of Wistar rats the doses administrated ranged between 66.7 
mg/kg b.w. day [49] and 500 mg/kg b.w./day [50]. So the doses given in Bnouham’s works 
were lower than the doses administrated in this thesis. 
In order to have an animal model of type 2 diabetes, or non-insulin dependent 
diabetes, a combination of high-fat feeding and streptozotocin injection were applied to the 
animals [75, 97]. 
Concerning overall growth and organ mass indices in rats, A. unedo extracts HF 
diet and STZ injection had significant effects on body mass gain, and consequently in body 
mass/body length ratio, and kidney size. In the case of body mass gain, the experimental 
group made diabetic lost body weight during the experiment. There was no significant 
change between the three diabetic groups, whether untreated or treated with the A. unedo 
extracts. The groups supplemented with the A. unedo extracts had a slight increase in body 
mass gain, although this increase was not statistically significant when compared to the 
diabetic group. As STZ destroys the pancreas β-cells and has a toxic effect, it was 
expectable to see a slight decrease in the animals’ body weight after the administration of 
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the agent [78]. Nevertheless, it was expectable that the rats lost weight after the diabetes 
induction, but gained it back while being feed with a high-fat diet.  In further studies 
conducted in the same lab, following the same procedure this happened: the diabetic rats 
put on weight [80, 98-100]. In another study where a STZ injection was used to induce 
type 2 diabetes, the rats showed a reduction of their body weighs compared to the normal 
rats [101]. Kasetti et al. related this phenomenon to poor glycaemic control [101]. 
According to this author, one possible explanation is that as rats cells fail to obtain glucose 
from the blood due to lack of insulin, they start obtaining it via gluconeogenesis which 
consumes muscular tissue in order to obtain aminoacids needed for this pathway. This led 
to muscle wasting and weight loss in these diabetic rats. The fact that the rats lost weight in 
this study influenced other parameters such as relative body mass weight and body 
mass/body length ratio. All the diabetic groups also presented an increased relative kidney 
size (expressed as percentage of the rat’s final body weight). Chronic hyperglycaemia is 
associated with a long list of organ damage and dysfunction leading to kidney failure. 
Kidney damage is called nephropathy. In an early stage of diabetes there is a kidney hyper 
function, associated with an increased glomerular size and microalbuminuria [52], so the 
kidneys size can be affected. No significant change was measured in the three diabetic 
groups (untreated and treated), suggesting that the injection of STZ combined with the 
high-fat diet had an effect on the size of the kidneys and that this was not caused or 
changed by the administration of the extracts. 
In this study, the blood glucose concentration was higher in all three diabetic 
groups (untreated and treated). Numerous other studies using STZ to induce diabetes 
confirmed this agent effectiveness to destroy pancreas β-cells and induce hyperglycaemia 
[60, 61, 65, 72, 101-112]. Nevertheless, supplementary A. unedo leaf and fruit extracts had 
a weak effect in lowering blood glucose. Even though the glucose levels were not as low as 
the ones presented by the control group, a slight decrease in glucose levels was noticed in 
treated groups.  
The hypoglycaemic potential of both Arbutus unedo L. extracts used in this trial 
seems to be rather weak. However this might be due to small doses administrated and/or 
short duration of treatment, applied in this experiment. In order to verify the hypothesis 
whether A. unedo fruit and leaves extracts have the hypoglycaemic potential, a follow up 
study using higher doses of the material and longer period of time is warranted. 
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The effect of the leaf and fruit aqueous extract was weak, especially when 
comparing with the results obtained with the root extract which was administrated in  
lower doses [49, 50]. One possible explanation is that the root material can have a higher 
dose of bioactive compounds. When comparing both compositions of fruit and roots some 
differences can be seen in terms of phenolic compounds (no data is available in the 
literature to compare other family of compounds). For example, in terms of anthocyanins 
roots have a content of 365mg/100g f.w. vs a 3.77mg/100g f.w. anthocyanin content of the 
fruits [29, 41]. Roots also have a flavones and flavonols content of 17mg/100g f.w. while 
fruits only have a flavonol content of 1.14 mg/100g of edible fruit [29, 41].  This can help 
explain why the root’s aqueous extract had a much higher hypoglycaemic effect, even 
when administrated in a lower dose. For example, catechin, a flavan-3-ol, was identified in 
the three materials. In roots it was not quantified, but in fruits and leaves it exists in 
different concentrations. According to Pallauf et al., catechin exists in the concentration of 
3.64 mg per 100 g of fresh fruit  [29]. According to Fiorentino et al. leaves have a catechin 
content of 54.6 mg per100g of fresh leaves [37]. The concentration of this compound is 
about 10 times higher in leaves, so in roots it can also exist in very different 
concentrations. As previously reported by Guimarães et al.,  bioactivity of  extracts from 
strawberry tree fruits can be more related to the phenolic compounds present in each 
extract than to their concentration [11]. The beneficial effects of the extracts can be 
attributed to various types of compounds existing in different concentrations in the plant 
materials. 
Supplementary Arbutus unedo L. leaf and fruit aqueous extract had some 
therapeutic/ preliminary positive effects in diabetic rats, which were presented in blood 
biochemistry parameters of rats’ serum, such as the serum concentration of glucose, 
phosphatase levels, creatinine, HOMA-IR index and insulin activity. No significant effects 
on blood lipid levels, AST, CRP, serum Fe and serum total protein were shown (data on 
Appendix 2). 
Diabetes is characterized by insulin resistance deficiency which leads to an 
unregulated carbohydrate metabolism. Insulin levels are lower in patients with diabetes 
which is a consequence of the malfunction of pancreas β-cells [52, 97]. Pancreas damage 
induced by STZ lowers circulating insulin levels [78]. The insulin levels of the group 
supplemented with Arbutus unedo L. leaf extract were similar as the ones presented by the 
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healthy control group while the fruit extract group presented a much more increased 
insulin concentration.  
The HOMA-IR index, defined as the fasting blood glucose to insulin ratio, is a 
good biomarker of insulin sensitivity. The higher this index the greater the insulin 
resistance [92]. In diabetes, the body’s insulin resistance is known to be greater. Same 
effect was reported in other studies using an STZ induction of diabetes in rats [102, 103, 
107]. As expected, the HOMA-IR index was much higher in the high-fat diet/STZ control 
group than in the control group. The increased HOMA-IR index is a reinforcement of the 
diabetic metabolic profile of these diabetic groups. Both supplementary Arbutus unedo L. 
extracts significantly reduced HOMA-IR index in diabetic rats, and this effect was a bit 
higher for the leaf extract supplemented group. But this should be confirmed using equal 
doses of the materials in a follow up study. 
Serum urea concentration was elevated in all the diabetic experimental groups and 
supplementary Arbutus unedo L. plant extracts did not change this concentration. Increased 
serum urea was also reported in the study of Kasetti et al. using STZ-diabetic rats [101]. 
Similarly, Jayanthy et al. used a high-fat feeding STZ induced  diabetic rats and reported 
the  increase in serum urea concentration in untreated animals [102]. Thereby this increase 
in the urea levels can be completely attributed to the diabetic state of the animals. Diabetes 
can lead to a condition named ketoacidosis which is diagnosed by an increased level of 
urea in the blood [52]. 
Another biomarker of diabetic ketoacidosis is an increased creatinine concentration 
in blood [52]. High creatinine levels can be caused by kidney dysfunction [52]. Jayanthy et 
al. studied the effect of high-fat diet feeding combined with STZ injection on this 
parameter and concluded that creatinine levels are higher in untreated diabetic rats [102]. 
The same happened in the STZ-diabetic rats used in the study of Kasetti [101]. The 
HF/STZ control group presented a high creatinine concentration. The groups supplemented 
with the Arbutus unedo L. plant extracts appeared to have a slightly decreased creatinine 
concentration, suggesting that there is a tendency in reducing these levels to the ones of the 
control group. In the diabetic groups, kidney mass was increased when compared to the 
control healthy rats that can be attributed to intense renal excretion of glucose and 
metabolites (leading to gradual kidney damage). Elevated concentration of serum urea and 
creatinine are good biomarkers of the hyperglycaemia which causes renal dysfunction. 
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The activity of aminotransferases (AST and ALT) in blood is used as an indicator 
of liver damage.  ALT (Alanine transaminase)  is an enzyme found most commonly in 
liver cells [52] and when elevated can indicate liver damage. When comparing the healthy 
control group and the diabetic control group a slight difference was found. In the study of 
Jayanthy et al. the ALT levels were increased in STZ-injected diabetic rats [102]. Similar 
trends were reported by other authors [72, 101, 105]. In this experiment, blood ALT was a 
bit elevated in the diabetic groups, but with high individual response within each group.  
Supplementary Arbutus unedo L. leaf extract increased blood ALT level, while the fruit 
extract had slightly weaker effect in diabetic rats. 
ALP (alkaline phosphatase) is another enzyme produced in the liver. An increase of 
this enzyme activity in blood can be a signal of liver disease: cholestasis, cirrhosis or 
tumours [52]. In this study, the diabetic not-treated group had the high activity of this 
enzyme. The same effect was reported in other studies in untreated diabetic rats [101, 102]. 
This may be explained with the fact that hyperglycaemia increases lipolysis and 
triglyceride breakdown. On the other hand, this increases the fatty acid content present in 
blood which will ultimately lead to an increased storage of this fatty acids in the liver [52]. 
The elevation of this enzyme in the diabetic study groups is due to the diabetic state they 
were in. Supplementary, Arbutus unedo L. leaf aqueous extract appeared to have some 
effects as blood ALP concentration showed a tendency to be reduced to levels presented by 
the control group. 
Blood morphology and haematology indices are routinely measured biomarkers 
taken into consideration in assessing health status. There were no significant changes in 
almost all of the tested blood morphology indexes with exception of platelets levels (PLT), 
red cell distribution width (RDW), Procalcitonin (PCT), lymphocytes and monocytes.  
Platelets levels were lower in the diabetic not treated group and on the A. unedo leaf 
aqueous extract supplemented group. However, the supplementation of A. unedo fruit 
aqueous extract revealed a tendency in contradicting this effect as the platelets levels 
slightly increased. The effects of insulin on platelets are reported by various and the results 
are controversial and contradictory. However,  one can say that there is a dysfunction in 
platelet signalisation and formation in diabetic patients [113]. This dysfunction appeared to 
be slightly attenuated by the supplementation of Arbutus unedo L. fruit extract. A further 
study with higher doses is once more needed. 
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The red cell distribution width (RDW) was higher in all the diabetic groups. A high 
RDW tells how the red blood cells vary in size. When analysing this parameter there is 
also a need to analyse the MCV (mean corpuscular). STZ injection, high-fat feeding or A. 
unedo extracts did not affect the MCV levels.  If the RDW level is increased and the MCV 
level is normal, it can indicate that the levels of folic acid decreased. This is the beginning 
stages of iron deficiency anaemia [114]. On the other hand, a recent study conducted by 
Magri et al. [115] found out that there can be an association between an elevated RDW and 
albuminuria in patients with a diabetic background as the diabetic state can be a cause of 
nephropathy. The authors proposed that a high RDW can be a marker for altered 
glomerular haemodynamics. Since diabetic nephropathy is associated with red cell 
fragmentation, high RDW can be related with diabetic renal disease [115]. Arbutus unedo 
L. extracts slightly improved the levels of RDW in diabetic rats, showing a tendency to 
decrease this levels to levels presented by the control group. 
Procalcitonin (PCT) is a peptide produced as a response to an inflammatory 
stimulus, namely bacterial infections [94]. In this trial the diabetic untreated group as well 
as the A. unedo leaf extract supplemented groups had a lower level of PCT compared to the 
healthy control group. In the A. unedo fruit extract supplemented group however, the PCT 
levels were the same as the ones presented by the control group. 
The high-fat feeding and STZ injection also decreased the amount of lymphocytes 
and monocytes. Similar effects were reported by Mojani et al. [97].  In a study with 
diabetic patients, Chang et al. [116] found that activated lymphocytes from patients with 
type 2 diabetes had a lower percentage of IL-2R in their membranes which resulted in 
insufficient proliferation. The glycosylation of membrane proteins caused by 
hyperglycaemia resulted in a failed signalling system of the lymphocytes and monocytes. 
The authors also concluded that the monocytes may not contribute to the insufficient 
lymphocyte proliferation presented in their study [116]. In the study conducted by Mojani 
et al. [97] diabetes affected lymphocytes proliferation. This suggests that the diabetic status 
of the animals can result in a reduced immunity. The treatment with the A. unedo aqueous 
extracts appears to attenuate these effects as the lymphocytes population were slightly 
higher in the groups fed with this extracts. Probably A. unedo may help enhance immune 
system but once more a longer study with higher doses could help clarifying these effects. 
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Diabetes can disturb the homeostasis of some microelements, namely zinc, copper 
and iron [64, 68]. In a diabetic type 1 animal model differences in tissular levels of these 
microelements were found [60, 112].  In order to clarify if STZ injection, high-fat feeding 
and A. unedo extracts had some effects on the tissular copper, zinc and iron levels in the 
rats, these parameters were also measured. Studies conducted in the same laboratory 
showed how STZ injection combined with high fat diets affected Cu, Zn and Fe 
homeostasis [98-100, 117]. However, the effect of A. unedo aqueous (or other type of) 
extracts on microelements status has not been studies yet.  
In this study, hepatic homeostasis of Cu, Zn and Fe was not disturbed by feeding 
high-fat diet combined with STZ injection. However, increased renal levels of these 
elements were observed.  
The high-fat feeding and the STZ injection themselves caused increased renal zinc 
concentration and supplementation with Arbutus unedo L. leaf aqueous extract did not 
contradict this effect. However, supplementation with Arbutus unedo L. fruit aqueous 
extracts slightly decreased the concentration of zinc in the rat’s kidneys to similar 
concentrations as the ones presented by the control group. Rats used as a model of type 2 
diabetes presented lower zinc levels in kidneys [59]. So the results in this thesis are rather 
contradictory. Nevertheless, in a further trial, Kazi et al.  found out that  high levels of Zn 
were present in urine of type 2 diabetic patients [118]. As kidneys are partly responsible 
for urine production, this can be an explanation for the high concentration of zinc in the 
rats’ kidneys. Further analysis to rats’ urine should be taken to clarify this.  
Arbutus unedo L. aqueous extracts given to diabetic rats showed no effect on 
copper renal concentrations, as they remained high. In another study conducted in the same 
laboratory with the same HF/STZ approach, high-fat diet combined with STZ injection 
also resulted in increased renal copper concentration [65, 98]. Apparently, A. unedo has no 
effect in regulating this mineral renal homeostasis. 
In a study by Takita et al., spontaneously diabetic rats  (considered a model for type 
2 diabetes), had a lower liver and serum Cu levels, while Fe levels were increased [119]. 
The authors concluded that metabolic changes associated with diabetes affects mineral 
balance in various organs.  
The high-fat feeding and the STZ injection themselves caused a slight increase in 
the renal iron concentration, while supplementation with Arbutus unedo L. leaf aqueous 
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extract aggravated this effect. Fruit aqueous extract had no effect in regulating this mineral 
homeostasis. Elevated kidney iron levels in HF/STZ rats were also reported in other studies 
[98, 99]. The Fe body levels in spontaneously diabetic rats were found to be higher too. 
This suggest that iron metabolism is altered in hyperglycaemia and insulin resistance  
[119]. In this study, HF/STZ rats presented a significantly higher RDW level while the 
MCV level remained normal which may indicate the beginning stages of iron deficiency 
anaemia. This could suggest problems with red blood cells function. Thus, these alterations 
in the renal Fe content as well as changes in red blood cells parameters can suggest a state 
of anaemia which is probably related to diabetes. Nevertheless the rats’ serum’s Fe levels 
remained normal. Most authors relate an increased ferritin concentration with a risk to 
develop diabetes [64, 67]. In this study, it can be proposed that the high-fat feeding 
combined with STZ injection can alone cause iron metabolism disturbances (that can 
worsen the diabetic state by aggravating the insulin resistance). Surprisingly this effect was 
higher in the group treated with the Arbutus unedo L. leaf extract than in the diabetic not 
treated group. Perhaps the rats in this group were most susceptible to these homeostasis 
alterations than the ones belonging to control group. The A. unedo leaf extract caused no 
alteration in the toxicity biomarkers, so renal toxicity of this material can be excluded. The 
fruit aqueous extract treated group also showed an increased renal iron concentration, 
similar to the one present in the diabetic not treated group. Once more, further trials should 
be carried out in other to prove its therapeutic or non-therapeutic benefits. In order to draw 
further conclusions about how the rats’ iron homeostasis was affected, more body tissues 
have to be analysed. 
When combining this mineral homeostasis data with organ size and haematogram 
index, it can be noticed that the altered value are related with kidney health. In this study, 
the diabetic rats had increased kidney mass and altered haematogram parameters which 
combined can indicate renal disease and disturbed kidney mineral homeostasis. Diabetes 
can ultimately lead to renal dysfunction [52, 120] which has been reported in diabetes in 
human subjects. In this study, diabetes caused by high-fat feeding combined with STZ 
injection lead to renal problems. Some light therapeutic effects were registered in the 
groups supplemented with Arbutus unedo L. aqueous extract (mainly the fruit extract) as 
the groups treated with this extracts had slightly improved levels of RDW. Further studies 
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with higher doses and longer duration are required in order to establish if these extracts 
have kidney protective effects. 
Lastly, the effect of the aqueous extracts from Arbutus unedo L. fruits and leaves on 
the expression of certain genes was also studied. To this date, the only studies concerning 
how extracts of A. unedo may influence gene expression only focus on genes involved in 
inflammatory processes [48, 121, 122]. Only one study in vivo was performed until now 
and the materials examined were cells subjected to acute inflammation or cancer cells.  
The genes examined in this study play a role in the glucose metabolism and/or in 
inflammation response. The expression of these genes on hepatic, muscular and fat tissues 
was analysed. 
There were significant changes in the expression of TNF-α on both hepatic and 
muscular tissues. Several studies using STZ induced type 2 diabetic rats have reported that 
these animals have an increased expression of TNF-α [72, 73, 104] in pancreas, liver, 
serum and fat tissue. As expected, the high-fat fed STZ injected type 2 diabetic control 
group showed an increased expression of the gene encoding to this cytokine. This 
expression was downregulated to normal values on hepatic tissue in the groups treated with 
both A. unedo leaf and fruit aqueous extract. In muscular tissue, the group treated with A. 
unedo fruit aqueous extract had normal expression of TNF-α gene, although the effect was 
not so high in the group treated with the leaf extract. In terms of regulation of TNF-α 
expression, the Arbutus unedo L. fruit and leaf extracts proved to have beneficial effects, in 
both hepatic and muscular tissues. Since high concentrations of TNF-α is associated with 
increased insulin resistance, the A. unedo extracts might have potential to attenuate 
inflammatory responses in type 2 diabetes. In a study by Mariotto et al., rats were 
subjected to carrageenan induced pleural and lung inflammation. One of the groups was 
also administered orally with 20mg GAE/ kg b.w. of Arbutus unedo L. leaf aqueous extract 
1h hour prior to carrageenan injection [48]. The authors concluded that this extract had 
anti-inflammatory properties [48]. In this thesis high-fat feeding and STZ injection 
increased the expression of TNF-α gene in liver and muscle tissues. Nevertheless, the 
treatment with both fruit and leaf aqueous extracts reduced the expression of this gene to 
normal levels. In muscular tissue, the effect was more potent for fruit extract. The doses 
tested, in terms of phenolic content were 3.146 mg GAE / kg b.w./ day for AUF group and 
12.225 mg GAE / kg b.w./ day for AUL group, much lower than the dose administrated in 
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the study of Mariotto. Even though, these lower doses proved to be effective. This is the 
first study reporting the A. unedo extracts can affect the TNF-α expression in different 
tissues of type 2 diabetic rats. 
Although in another study using STZ injection to induce non-insulin dependent 
diabetes in rats, the IL-6 levels were enhanced in pancreas, kidney and serum [123]. IL-6 is 
thought to induce insulin resistance in liver as it is associated with inhibition of hepatic 
insulin-dependent receptor [123]. No statistically significant changes occurred in the 
expression of this gene in all experimental groups in the different tissues. 
Arya et al. using STZ diabetic rats revealed that pro-inflammatory cytokines have 
antagonistic properties to insulin as they interfere with IRS phosphorylation, leading to 
insulin resistance [123]. There is, thereby a link between oxidative stress, inflammation, 
inflammatory cytokines and type 2 diabetes, as in their study the elevated levels of TNF-α 
and IL-6 in the serum and tissues of STZ rats suggested an inflammatory state which lead 
to insulin resistance [123]. 
The link between diabetes, insulin pathway and the interference of pro 
inflammatory cytokine cannot be dismissed. So, the expression of the genes encoding for 
IRS-2 and transporters GLUT-2 and GLUT-4 were evaluated in order to clarify whether 
insulin resistance and diabetic state would affect their expression 
The IRS-2 gene encodes a protein named Insulin Receptor Substrate 2, a 
cytoplasmic molecule that acts as a molecular adaptor in the tyrosine kinase cascade, 
thereby mediating the effect of insulin as well as other proteins. IRS-2 is tightly related 
with diabetes and previous studies that also used SZT-injected diabetic rats reported that 
the animals had decreased expression of this gene [105, 108]. Insulin resistance is thought 
to be directly linked with deficient IRS-2 production, and this decreased IRS-2 expression 
was also reported in STZ-rats that were fed with an high-fat diet [124]. The same effect 
was thought to occur in this thesis. No significant changes in the expression of this gene 
were seen in hepatic and muscular tissues. The only significant changes in the expression 
of this gene occurred in fat tissue. However, the results obtained in the fat tissue were even 
more contradictory with the diabetic not treated group having an increased expression of 
this gene. The supplementation with Arbutus unedo L. extracts showed some effects in this 
matter. The expression of IRS-2 gene in A. unedo supplemented groups was a bit lower 
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than in the diabetic group. To further clarify this matter, analysis of related proteins 
involved in the insulin signalizing cascade should be performed.  
In this study, in the diabetic rats (not treated group), the expression of GLUT-4 
encoding gene in muscle tissue was greater than in the control group. This is opposite to 
the data available in the literature [106-108, 110, 111]. In all these studies, GLUT-4 
expression and/or release decreased in STZ diabetic rats’ muscular tissue. In muscle tissue 
A. unedo had a slight effect in “regulating” this gene expression as the expression remained 
a bit lower. In fat tissue and hepatic tissue, no significant difference occurred between any 
of the groups. 
As the high-fat feeding and STZ-injection had no effect in decreasing the 
expression of IRS-2 in hepatic, fat and muscular tissue, this can help explain why these 
results were contradictory. Decreased GLUT-4 translocation has been observed by many 
researchers in STZ induced diabetic rats that reflects insulin resistance related to decreased 
ILR-2 expression. In fat tissue, the expression of IRS-2 was greatly enhanced.  
In the case of GLUT-2 gene expression, studies with STZ rats reported that the 
hepatic levels of GLUT-2 have decreased [109, 110]. In this experiment such changes were 
not detected, as there were no significant changes in GLUT-2 expression in liver tissue. In 
muscular tissue, diabetic not treated rats did not present an increased expression of this 
gene when compared with the control group rats. The treatment with Arbutus unedo L. 
fruit aqueous extract enhanced even more this expression. Leaf extract has increased the 
gene’s expression a bit. However, no therapeutic effects can be attributed to these extracts 
before clarifying why the expression of GLUT-2 did not change in the diabetic group. 
Arbutus unedo L. aqueous extracts enhanced the expression of both GLUTs in the 
analysed tissues. In case of diabetes, this can be considered as beneficial although further 
clarifications are needed. Beneficial effects were seen in the modulation of the expression 
of TNF-α in a rat diabetic model.  
In conclusion, this was the first trial which tested the therapeutic potential of 
Arbutus unedo L. fruit and leaf aqueous extracts given orally in small doses in an animal 
model of type 2 diabetes. Until now, no other study has explored so many parameters 
(blood indices, mineral status and gene expression) and correlated them with diabetes. 
Positive anti-diabetic and anti-inflammatory aspects were found for both aqueous extracts. 
Arbutus unedo L. fruit aqueous extract presented a tendency towards lowering blood 
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glucose levels. More beneficial effects were seen for this extract in terms of attenuating the 
effects of diabetes in renal zinc homeostasis and blood morphology and haematological 
parameters and regulating TNF-α gene expression in muscular tissue.  
The other type of extract tested, the leaf extract, appeared to be more efficient in 
regulating insulin levels, decreasing HOMA-IR index and also presented a tendency 
towards lowering blood glucose levels. It also had a slight effect in decreasing phosphatase 
concentration. 
Both extracts proved to efficiently improve insulin sensitivity (HOMA-IR index), 
slightly decreasing serum creatinine concentration, slightly improved the RDW-SD and 
lymphocytes concentration and decreasing TNF-α expression on liver and muscle tissue.  
Although few effects were observed, one should notice that the doses tested were 
small and that the trial took place for a short period of time. Nevertheless, further 
investigation is needed and this trial was the bottom line in investigating the beneficial 
effects of Arbutus unedo L. 
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The aim of this study was to create the laboratory conditions to obtain the Arbutus 
unedo L. extracts and further to evaluate their antidiabetic and anti-inflammatory potential 
in a diabetic model of rats. 
After careful analysis of available literature about the bioactive properties of A. 
unedo extracts, the fruit and leaf aqueous extracts were selected as appropriate materials 
for an in vivo trail. The aqueous extracts had already been used in the study of antidiabetic 
and anti-inflammatory potential of A. unedo plant materials. As this study was an in vivo 
study, it was decided that the type of extracts should be the least harmful possible. 
In the first stage of experiment, different extraction conditions were tested to 
obtain the materials regarding the best yield and phenolic content. In order to obtain fruit 
aqueous extract, the optimal conditions were determined as being 5 grams of fruit powder 
in 250 mL of water at 90ºC during 45 minutes.  The extraction conditions used in order to 
obtain the leaf aqueous extract were not optimized. The procedure used to obtain the leaf 
extract was the same as reported in the literature 5 grams of powdered leaves in 250 mL of 
water at 100ºC during 45 minutes [39]. 
It was found that the extraction yield of fruits and leaf extracts were not similar, as 
the yield obtained for the fruit extract was 78.4 % (w/w) and the yield obtained for leaf 
extract was 31.8 % (w/w). The total phenolic content in the fruit extract was 2.517 mg 
GAE/g of extract and in the leaf extract was 24.450 mg GAE/ g of extract. So, the total 
phenolic content of the leaf extract was 10-fold of that in the fruit ones. This was taken into 
consideration when selecting the doses administrated on the in vivo trial. 
In the second stage of experiment, both Arbutus unedo L. aqueous extracts were 
given orally to male Wistar rats made diabetic by feeding high-fat diet and STZ-injection. 
Due to limited amount of materials, diabetic rats received in food variable doses 
of extracts, namely fruit extract -1.25g /kg b.w./day and leaf extract - 0.5g /kg b.w./day for 
4 weeks. The working aim of the biophase was to evaluate the effects of these extracts on 
nutritional indices, blood haematological and biochemical indices, mineral status (Fe, Zn 
and Cu) and studying the expression of selected genes related with inflammatory response 
and glucose metabolism (TNF-α, IRS-2, IL-6, GLUT-2 and GLUT-4 encoding genes). The 
study of mineral status was made in hepatic and renal tissues and the evaluation of gene 
expression was made in fat, muscular and liver tissues. 
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It was found that A. unedo leaf and fruit aqueous extracts exerted moderate anti-
diabetic, anti-inflammatory and protective effects on kidney function in diabetic rats. 
Although both extracts (in the given doses and treatment time) did not significantly 
decrease blood glucose concentration, they presented a preliminary positive antidiabetic 
potential. They clearly improved insulin sensitivity (HOMA-IR index), slightly improved 
the RDW-SD value, platelets levels and lymphocytes concentration; slightly decreased 
serum creatinine and phosphatase levels and significantly decreased TNF-α expression in 
liver and muscular tissues. In some of the analysed parameters, although the results may 
not be statistically different, there was a tendency towards normalizing them to healthy 
control levels. These preliminary results are important guide lines to follow up studies. 
When comparing the activity of A. unedo leaf and fruit extracts, some differences were 
found: 
 Arbutus unedo L. leaf extract was more efficient in decreasing insulin levels 
and decreasing HOMA-IR index. 
 Arbutus unedo L. fruit extract was more potent in regulating TNF-α gene 
expression in muscular tissue.  
This is the first trial showing that A. unedo extracts have some therapeutic potential 
for improving blood glucose, insulin and insulin sensitivity, and anti-inflammatory 
response in a diabetic rat model. The only trials on A. unedo anti diabetic activity available 
until now have used roots aqueous extract [49, 50]. Although the doses tested in this thesis 
were higher, the hypoglycaemic effect was not as potent as the one noticed in the previous 
works. As roots, fruits and leaves from the strawberry tree have different compositions, 
this can be an explanation for this weak anti diabetic effect. As roots are not as well studied 
as the fruit and leaves this effect cannot be attributed to any specific compound. 
Even if it did not have a hypoglycaemic effect as strong as expected, the A. unedo 
leaf and fruit extracts cause some alterations in mineral homeostasis and gene expression. 
It has been reported in the literature that diabetes affects more parameters than only 
glucose and lipid metabolism. The high-fat feeding and STZ injection had disturbed zinc 
homeostasis in kidneys causing an increase in this mineral’s concentration. Although this 
effect was not reported in further studies A. unedo fruit extract slightly decreased this 
mineral concentration. In this case, one can say that the effect of diabetes was attenuated 
by the supplementation with this extract. In terms of the expression of inflammatory 
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related genes and improving immunity, positive effects were also shown. As reported in 
literature [48], A. unedo downregulates the expression of TNF-α in inflammatory response. 
The same was observed in this thesis in muscle and liver tissues. Besides, this was the first 
time this gene’s analysis was made in a type 2 diabetes model. 
This study is the bottom line in this subject as no other had correlated and 
investigated so many diabetes related effects. The results demonstrate that there is a 
potential therapeutically application for this plant. Further investigation is needed in order 
to clarify the beneficial effects of Arbutus unedo L. Although the strawberry tree is spread 
all over the Portuguese and south Europe territory, is not very well known by the 
community. These preliminary results can lead to a valorisation of this plant and to 
improve the existing knowledge.  
 
In terms of futures perspectives, further study is necessary to confirm these effects. 
More refined experimental models must be used, involving identification of major 
bioactive compounds, dose-response relationship, and longer duration of treatment. It 
would also be interesting to further investigate how these extracts affect selected gene 
expression. It would be also interesting to test other types of extracts or to administrate the 
freeze dried fruits and leaves of Arbutus unedo L. directly on the high-fat diets. In any 
extracting process, a fraction of the material’s compounds is lost. So, giving the whole fruit 
to the animals will make it possible to study all the fruit’s potential. 
In order to explain the bioactive properties of the extracts, the extracts’ 
composition in terms of phenolic compounds ought to be analysed. Other bioactive 
compounds should be also analysed as the extract has a “mix” of compounds that are likely 
to act simultaneously in order to present these therapeutic effects.  
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Appendix 1- TPC measurement by Folin-Ciocalteau method 
Table 16: Absorbance at 760 nm measured for each gallic acid solution used to plot the 
method’s calibration curve. 
[Gallic Acid] 
(mg/L) 
A 760 nm Mean 
A 760 nm 
SD 
61.995 
 
0.262 0.274 0.0125 
0.287 
0.274 
123.99 
 
0.513 0.523 0.00907 
0.530 
0.527 
186 
 
0.729 0.723 0.00603 
0.717 
0.724 
248 
 
0.869 0.901 0.0289 
0.925 
0.910 
310 
 
 
1.224 1.251 0.0249 
1.256 
1.273 
0 
 
0.057 0.062 0.00839 
0.072 
0.058 
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Appendix -2 In vivo effects of the Arbutus unedo L. fruit and leaf aqueous extract in 
high-fat feed STZ-diabetic rats. 
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Figure 33: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in food intake 
(g per day).  
 
Liver %
0
1
2
3
4
5
No-Diabetes/Control
Diabetes/No-Treatment
AUL
AUF
%
 b
o
d
y
 m
a
s
s
 
Figure 34: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in liver 
weight (% of rat’s body mass).  
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Figure 35: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in heart 
weight (% of rat’s body mass).  
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Figure 36: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in testis 
weight (% of rat’s body mass).  
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Figure 37: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in pancreas 
weight (% of rat’s body mass).  
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Figure 38: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in spleen 
weight (% of rat’s body mass).  
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Figure 39: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in left femur 
weight (% of rat’s body mass).  
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Figure 40: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in right 
femur weight (% of rat’s body mass).  
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Figure 41: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum 
HDL levels (mg dL 
-1
).  
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Figure 42: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum 
LDL levels (mg dL 
-1
).  
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Figure 43: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum total 
protein levels (g dL 
-1
).  
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Figure 44:  Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum 
CRP levels (mg L 
-1
).  
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Figure 45: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum total 
Cholesterol levels (mg dL 
-1
).  
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Figure 46: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum 
Triacylglycerol levels (mg dL 
-1
).  
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Figure 47: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum AST 
(U L 
-1
).  
Fe
0
50
100
150
200
No-Diabetes/Control
Diabetes/No-Treatment
AUL
AUF

g
 d
L
-1
 
Figure 48: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in serum iron 
levels (µg dL 
-1
).  
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Figure 49: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in white 
blood cell levels.  
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Figure 50: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in red blood 
cell levels.  
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Figure 51: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in 
haemoglobin levels.  
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Figure 52: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
haematocrit.  
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Figure 53: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the mean 
corpuscular volume.  
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Figure 54: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the mean 
corpuscular hemoglobin.  
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Figure 55: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the mean 
corpuscular haemoglobin concentration.  
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Figure 56: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the red 
blood cell distribution width. Bars with SD bars without common superscript differ 
significantly (p < 0.05). 
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Figure 57: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the platelet 
distribution width.  
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Figure 58: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the mean 
platelet volume.  
 
121 
 
P-LCR
0
5
10
15
No-Diabetes/Control
Diabetes/No-Treatment
AUL
AUF
%
 
Figure 59: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the platelet 
larger cell ratio.  
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Figure 60: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
neutrophils levels.  
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Figure 61: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
eosinophils levels.  
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Figure 62: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
basophils levels.  
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Figure 63: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the copper 
concentration in liver tissue (µg 
-1
 dry mass).  
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Figure 64: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the zinc 
concentration in liver tissue (µg 
-1
 dry mass).  
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Figure 65: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the iron 
concentration in liver tissue (µg 
-1
 dry mass).  
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Figure 66: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of TNF alpha gene in fat tissue.  
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Figure 67: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of IRS gene in hepatic tissue.  
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Figure 68: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of IRS gene in muscular tissue.  
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Figure 69: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of GLUT-4 gene in hepatic tissue. 
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Figure 70: Effect of high-fat diets (No-Diabetes/Control), STZ injection (Diabetes/No-
treatment) and Arbutus unedo L. leaf (AUL) and fruit (AUF) aqueous extract in the 
expression of GLUT-2 gene in hepatic tissue. 
 
 
 
 
 
 
 
